Skip to Main Content
YSM Home

INFORMATION FOR

DownloadHi-Res Photo

A. David Paltiel, MBA, PhD

Professor of Public Health (Health Policy), Professor of Management, and Professor in the Institution for Social and Policy Studies; Co-director, Public Health Modeling Concentration; Affiliated Faculty, Yale Institute for Global Health

Contact Information

A. David Paltiel, MBA, PhD

Mailing Address

  • Health Policy & Management

    60 College Street

    New Haven, CT 06510

    United States

Download CV

Related Links

Research Summary

The objective that guides Dr. Paltiel's scholarly activities is to promote a reasoned approach to choices under uncertainty and resource scarcity in health and medicine. Trained in the field of Operations Research, Dr. Paltiel designs and implements model-based cost-effectiveness analyses of medical technologies and public health interventions. His published research, including more than 100 peer-reviewed papers, spans both methods development and applications to a wide range of disease areas and clinical specialties. He has a special interest and expertise in HIV/AIDS and has published broadly on the cost-effectiveness of testing, prevention, treatment, and care, both in the United States and around the world.

Among the many talented modelers at Yale, Dr. Paltiel's unique contribution lies in bringing a decision-analytic and cost-effectiveness overlay to public health policy and resource allocation. His expertise in both the theory of choice under uncertainty and its practical adaptation to policy-relevant applications provides substantial opportunity to mentor colleagues interested in promoting a more reasoned approach to clinical practice and priority setting in health and medicine.

Specialized Terms: Operations research; Disease simulation modeling

Extensive Research Description

  1. Novel approaches to the design and evaluation of combination HIV prevention. The goals of this NIMH-funded grant project are to develop and illustrate three novel ways of thinking about HIV prevention program design and evaluation: viewing HIV prevention in terms of policy bundles; looking beyond program cost-effectiveness to program affordability; and designing financial incentives that translate into better long-term HIV outcomes. The broad objective that guides this research is to squeeze the greatest possible benefit out of every HIV prevention dollar.
  2. Economic Modeling for HIV, Viral Hepatitis, STD, TB and School Health. The goal of this CDC-funded collaborative grant to the Harvard School of Public Health (Principal Investigator: Joshua Salomon) is to conduct health and economic modeling to inform decision-making on HIV, hepatitis, STD, TB and school health at national, state and local levels, in partnership with the National Center for HIV/AIDS Viral Hepatitis, STD and TB Prevention.
  3. Cost-Effectiveness of Preventing AIDS Complications (CEPAC-US). The goal of this NIAID-funded collaborative grant to Massachusetts General Hospital (Principal Investigator: Kenneth Freedberg) is to develop a computer simulation model of advanced HIV disease and use to project the costs and consequences of alternative patient care strategies.
  4. Optimizing HIV Care in Less Developed Countries (CEPAC-International). The goal of this NIAID-funded collaborative grant to Massachusetts General Hospital (Principal Investigator: Kenneth Freedberg) is to provide mentoring for young investigators in patient-oriented HIV research and use ongoing HIV simulation model in conjunction with mentoring efforts to address critical HIV clinical management questions in the US and internationally.
  5. Making Better Decisions: Policy Modeling for AIDS & Drug Abuse. The goal of this NIDA-funded collaborative grant to Stanford University (Principal Investigator: Douglas Owens) is to develop and apply mathematical policy modeling techniques to the evaluation of AIDS‑related public health interventions.
  6. Novel Methods to Inform HIV/TB Clinical Trial Development. The goals of this NIAID-funded collaborative grant (Principal Investigator: Rochelle Walensky) are to apply a mathematical simulation modeling framework, based on the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) Model, to the NIAID/ACTG clinical trials infrastructure. We propose to inform the development, design, and assessment of therapeutic, diagnostic, and 'strategy' clinical trials in HIV/TB care in international settings. The ultimate goal of this project is to apply novel scientific methods in a highly innovative fashion, to maximize trial investments. It will develop new scientific knowledge of value to HIV/TB investigators, as well as clinical trialists in many areas of medicine.
  7. Typhoid modeling studies for typhoid conjugate vaccine cost effectiveness and for typhoid delivery strategy. The goals of this project, funded by a grant from the Bill & Melinda Gates Foundation (Principal Investigator: Virginia E. Pitzer), are to conduct research aimed toward the prevention of HIV infection and the reduction of the negative consequences of HIV disease in vulnerable and underserved populations in the U.S.
  8. A unified intervention for young gay and bisexual men's minority stress, mental health, and HIV risk. The goals of this NIMH-funded grant (Principal Investigator: John Pachankis) are to address key sources of HIV risk among MSM, including stigma-related stress and associated mental health and substance use difficulties, and to use the intervention developed in this project to reduce HIV risk behavior among MSM and therefore the spread of HIV.
  9. Improving HIV Prevention and Treatment in Ukraine through Innovations in Healthcare Integration for People Who Inject Drugs. The goals of this NIDA-funded grant (Principal Investigator: Frederick L. Altice) are to use a multi-level, implementation science framework and multi-site cluster design to compare Quality of Health Indicator outcomes in PWIDs treated in integrated primary care centers with those who receive standard of care.

Coauthors

Research Interests

Acquired Immunodeficiency Syndrome; France; Health Policy; Health Resources; HIV; India; Operations Research; South Africa

Public Health Interests

Community Health; Health Care Management; Health Policy; HIV/AIDS; Infectious Diseases; Mental Health; Substance Use, Addiction; Health Equity, Disparities, Social Determinants and Justice; COVID-19

Selected Publications

  • Cost‐effectiveness of hepatitis C virus test‐and‐treat and risk reduction strategies among men who have sex with men living with HIV in FranceCastry M, Cousien A, Champenois K, Supervie V, Velter A, Ghosn J, Yazdanpanah Y, Paltiel A, Deuffic‐Burban S. Cost‐effectiveness of hepatitis C virus test‐and‐treat and risk reduction strategies among men who have sex with men living with HIV in France Journal Of The International AIDS Society 2022, 25: e26035. PMID: 36451286, PMCID: PMC9712801, DOI: 10.1002/jia2.26035.
  • Population-level strategies for nirmatrelvir/ritonavir prescribing - a cost-effectiveness analysisSavinkina A, Paltiel A, Ross J, Gonsalves G. Population-level strategies for nirmatrelvir/ritonavir prescribing - a cost-effectiveness analysis Open Forum Infectious Diseases 2022 DOI: 10.1093/ofid/ofac637.
  • Population-Level Strategies for Nirmatrelvir/Ritonavir Prescribing—A Cost-effectiveness AnalysisSavinkina A, Paltiel A, Ross J, Gonsalves G. Population-Level Strategies for Nirmatrelvir/Ritonavir Prescribing—A Cost-effectiveness Analysis Open Forum Infectious Diseases 2022, 9: ofac637. PMID: 36589482, PMCID: PMC9792084, DOI: 10.1093/ofid/ofac637.
  • Does gabapentin provide benefit for patients with knee OA? A benefit-harm and cost-effectiveness analysis.Bensen G, Rogers A, Leifer V, Edwards R, Neogi T, Kostic A, Paltiel A, Collins J, Hunter D, Katz J, Losina E. Does gabapentin provide benefit for patients with knee OA? A benefit-harm and cost-effectiveness analysis. Osteoarthritis And Cartilage 2022 PMID: 36414225, DOI: 10.1016/j.joca.2022.07.013.
  • The Cost‐Effectiveness of Weight Loss Interventions Prior to Total Knee Replacement for Patients with Class III ObesityKostic AM, Leifer VP, Selzer F, Hunter DJ, Paltiel AD, Chen AF, Robinson MK, Neogi T, Collins JE, Messier SP, Edwards RR, Katz JN, Losina E. The Cost‐Effectiveness of Weight Loss Interventions Prior to Total Knee Replacement for Patients with Class III Obesity Arthritis Care & Research 2022 PMID: 36250415, DOI: 10.1002/acr.25044.
  • Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling studySavinkina A, Bilinski A, Fitzpatrick M, Paltiel AD, Rizvi Z, Salomon J, Thornhill T, Gonsalves G. Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study BMJ Open 2022, 12: e061752. PMID: 36100306, PMCID: PMC9471205, DOI: 10.1136/bmjopen-2022-061752.
  • Cost‐Effectiveness of Arthroscopic Partial Meniscectomy and Physical Therapy for Degenerative Meniscal TearWilliams EE, Katz JN, Leifer VP, Collins JE, Neogi T, Suter LG, Levy B, Farid A, Safran‐Norton C, Safran‐Norton C, Paltiel AD, Losina E. Cost‐Effectiveness of Arthroscopic Partial Meniscectomy and Physical Therapy for Degenerative Meniscal Tear ACR Open Rheumatology 2022, 4: 853-862. PMID: 35866194, PMCID: PMC9555200, DOI: 10.1002/acr2.11480.
  • Societal Cost of Opioid Use in Symptomatic Knee Osteoarthritis Patients in the United StatesHuizinga JL, Stanley EE, Sullivan JK, Song S, Hunter DJ, Paltiel AD, Neogi T, Edwards RR, Katz JN, Losina E. Societal Cost of Opioid Use in Symptomatic Knee Osteoarthritis Patients in the United States Arthritis Care & Research 2022, 74: 1349-1358. PMID: 33629485, PMCID: PMC8382774, DOI: 10.1002/acr.24581.
  • VALUE OF USING GABAPENTIN FOR KNEE OA PATIENTS: A COST-EFFECTIVENESS ANALYSIS.Bensen G, Rogers A, Leifer V, Edwards R, Neogi T, Kostic A, Paltiel A, Collins J, Hunter D, Katz J, Losina E. VALUE OF USING GABAPENTIN FOR KNEE OA PATIENTS: A COST-EFFECTIVENESS ANALYSIS. Osteoarthritis And Cartilage 2022, 30: s261-s262. DOI: 10.1016/j.joca.2022.02.357.
  • Reliability of patient self-reports to clinician-assigned functional scores of inclusion body myositisRoy B, Zubair A, Petschke K, O'Connor KC, Paltiel AD, Nowak RJ. Reliability of patient self-reports to clinician-assigned functional scores of inclusion body myositis Journal Of The Neurological Sciences 2022, 436: 120228. PMID: 35344793, DOI: 10.1016/j.jns.2022.120228.
  • Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness Analysis.Neilan AM, Landovitz RJ, Le MH, Grinsztejn B, Freedberg KA, McCauley M, Wattananimitgul N, Cohen MS, Ciaranello AL, Clement ME, Reddy KP, Hyle EP, Paltiel AD, Walensky RP. Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness Analysis. Annals Of Internal Medicine 2022, 175: 479-489. PMID: 35099992, PMCID: PMC9087297, DOI: 10.7326/m21-1548.
  • Responding to SARS-CoV-2 on College Campuses—Only Beginning to Understand What Works and WhyPaltiel AD. Responding to SARS-CoV-2 on College Campuses—Only Beginning to Understand What Works and Why JAMA Network Open 2021, 4: e2138904. PMID: 34902042, DOI: 10.1001/jamanetworkopen.2021.38904.
  • COVID-19 Testing and Case Rates and Social Contact Among Residential College Students in Connecticut During the 2020-2021 Academic YearSchultes O, Clarke V, Paltiel AD, Cartter M, Sosa L, Crawford FW. COVID-19 Testing and Case Rates and Social Contact Among Residential College Students in Connecticut During the 2020-2021 Academic Year JAMA Network Open 2021, 4: e2140602. PMID: 34940864, PMCID: PMC8703252, DOI: 10.1001/jamanetworkopen.2021.40602.
  • Adventures in COVID-19 Policy Modeling: Education EditionGonsalves GS, Salomon JA, Thornhill T, Paltiel AD. Adventures in COVID-19 Policy Modeling: Education Edition Current HIV/AIDS Reports 2021, 19: 94-100. PMID: 34826066, PMCID: PMC8617548, DOI: 10.1007/s11904-021-00592-9.
  • Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021Paltiel AD, Schwartz JL. Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021 Annals Of Internal Medicine 2021, 174: m21-2965. PMID: 34461034, PMCID: PMC8422997, DOI: 10.7326/m21-2965.
  • Reducing the Prevalence of Alcohol-Exposed Pregnancies in the United States: A Simulation Modeling StudyYaesoubi R, Mahin M, Martin G, Paltiel AD, Sharifi M. Reducing the Prevalence of Alcohol-Exposed Pregnancies in the United States: A Simulation Modeling Study Medical Decision Making 2021, 42: 217-227. PMID: 34166146, PMCID: PMC8702569, DOI: 10.1177/0272989x211023203.
  • Maximizing the Efficiency of Active Case Finding for SARS-CoV-2 Using Bandit AlgorithmsGonsalves GS, Copple JT, Paltiel AD, Fenichel EP, Bayham J, Abraham M, Kline D, Malloy S, Rayo MF, Zhang N, Faulkner D, Morey DA, Wu F, Thornhill T, Iloglu S, Warren JL. Maximizing the Efficiency of Active Case Finding for SARS-CoV-2 Using Bandit Algorithms Medical Decision Making 2021, 41: 970-977. PMID: 34120510, PMCID: PMC8484027, DOI: 10.1177/0272989x211021603.
  • The Value of Total Knee Replacement in Patients With Knee Osteoarthritis and a Body Mass Index of 40 kg/m2 or Greater : A Cost-Effectiveness Analysis.Chen AT, Bronsther CI, Stanley EE, Paltiel AD, Sullivan JK, Collins JE, Neogi T, Katz JN, Losina E. The Value of Total Knee Replacement in Patients With Knee Osteoarthritis and a Body Mass Index of 40 kg/m2 or Greater : A Cost-Effectiveness Analysis. Annals Of Internal Medicine 2021, 174: 747-757. PMID: 33750190, PMCID: PMC8288249, DOI: 10.7326/m20-4722.
  • The Dynamics of Infectious Diseases Associated With Injection Drug Use in Lawrence and Lowell, MassachusettsGonsalves GS, Paltiel A, Thornhill T, Iloglu S, DeMaria A, Cranston K, Klevens R, Klevens R, Walensky RP, Warren JL. The Dynamics of Infectious Diseases Associated With Injection Drug Use in Lawrence and Lowell, Massachusetts Open Forum Infectious Diseases 2021, 8: ofab128. PMID: 34189158, PMCID: PMC8231383, DOI: 10.1093/ofid/ofab128.
  • Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission.Paltiel AD, Zheng A, Sax PE. Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission. Annals Of Internal Medicine 2021, 174: 803-810. PMID: 33683930, PMCID: PMC9317280, DOI: 10.7326/m21-0510.
  • Clinical and Economic Impact of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission.Paltiel AD, Zheng A, Sax PE. Clinical and Economic Impact of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission. MedRxiv : The Preprint Server For Health Sciences 2021 PMID: 33564779, PMCID: PMC7872371, DOI: 10.1101/2021.02.06.21251270.
  • Adaptive Policies to Balance Health Benefits and Economic Costs of Physical Distancing Interventions during the COVID-19 PandemicYaesoubi R, Havumaki J, Chitwood MH, Menzies NA, Gonsalves G, Salomon JA, Paltiel AD, Cohen T. Adaptive Policies to Balance Health Benefits and Economic Costs of Physical Distancing Interventions during the COVID-19 Pandemic Medical Decision Making 2021, 41: 386-392. PMID: 33504258, PMCID: PMC8084913, DOI: 10.1177/0272989x21990371.
  • Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine DeploymentPaltiel AD, Zheng A, Schwartz JL. Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment Annals Of Internal Medicine 2021, 174: m20-7866. PMID: 33395345, PMCID: PMC7787166, DOI: 10.7326/m20-7866.
  • Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over EfficacyPaltiel AD, Schwartz JL, Zheng A, Walensky RP. Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy Health Affairs 2020, 40: 42-52. PMID: 33211536, PMCID: PMC7931245, DOI: 10.1377/hlthaff.2020.02054.
  • Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approachCastry M, Cousien A, Supervie V, Velter A, Ghosn J, Paltiel AD, Yazdanpanah Y, Deuffic-Burban S. Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach Gut 2020, 70: 1561-1569. PMID: 33109688, DOI: 10.1136/gutjnl-2020-321744.
  • Quality‐Adjusted Life‐Years Lost Due to Physical Inactivity in a US Population With OsteoarthritisLosina E, Silva GS, Smith KC, Collins JE, Hunter DJ, Shrestha S, Messier SP, Yelin EH, Suter LG, Paltiel AD, Katz JN. Quality‐Adjusted Life‐Years Lost Due to Physical Inactivity in a US Population With Osteoarthritis Arthritis Care & Research 2020, 72: 1349-1357. PMID: 31350803, PMCID: PMC6982563, DOI: 10.1002/acr.24035.
  • Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis.Walensky RP, Horn T, McCann NC, Freedberg KA, Paltiel AD. Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis. Annals Of Internal Medicine 2020, 173: 507-508. PMID: 32926822, DOI: 10.7326/l20-0693.
  • Has depression surpassed HIV as a burden to gay and bisexual men’s health in the United States? A comparative modeling studyBromberg DJ, Paltiel AD, Busch SH, Pachankis JE. Has depression surpassed HIV as a burden to gay and bisexual men’s health in the United States? A comparative modeling study Social Psychiatry And Psychiatric Epidemiology 2020, 56: 273-282. PMID: 32785755, PMCID: PMC7870461, DOI: 10.1007/s00127-020-01938-1.
  • Cost-effectiveness of Frequent HIV Screening Among High-risk Young Men Who Have Sex With Men in the United States.Neilan AM, Bulteel AJB, Hosek SG, Foote JHA, Freedberg KA, Landovitz RJ, Walensky RP, Resch SC, Kazemian P, Paltiel AD, Weinstein MC, Wilson CM, Ciaranello AL. Cost-effectiveness of Frequent HIV Screening Among High-risk Young Men Who Have Sex With Men in the United States. Clinical Infectious Diseases 2020, 73: e1927-e1935. PMID: 32730625, PMCID: PMC8492162, DOI: 10.1093/cid/ciaa1061.
  • COVID-19 screening strategies that permit the safe re-opening of college campuses.Paltiel AD, Zheng A, Walensky RP. COVID-19 screening strategies that permit the safe re-opening of college campuses. MedRxiv : The Preprint Server For Health Sciences 2020 PMID: 32676614, PMCID: PMC7359539, DOI: 10.1101/2020.07.06.20147702.
  • Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United StatesPaltiel AD, Zheng A, Walensky RP. Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States JAMA Network Open 2020, 3: e2016818. PMID: 32735339, PMCID: PMC7395236, DOI: 10.1001/jamanetworkopen.2020.16818.
  • Waiting for Certainty on Covid-19 Antibody Tests — At What Cost?Weinstein MC, Freedberg KA, Hyle EP, Paltiel AD. Waiting for Certainty on Covid-19 Antibody Tests — At What Cost? New England Journal Of Medicine 2020, 383: e37. PMID: 32501664, DOI: 10.1056/nejmp2017739.
  • Adaptive policies for use of physical distancing interventions during the COVID-19 pandemic.Yaesoubi R, Havumaki J, Chitwood M, Menzies NA, Gonsalves G, Salomon JA, Paltiel AD, Cohen T. Adaptive policies for use of physical distancing interventions during the COVID-19 pandemic. MedRxiv : The Preprint Server For Health Sciences 2020 PMID: 32577698, PMCID: PMC7302307, DOI: 10.1101/2020.05.29.20065714.
  • Novel microsimulation model of tobacco use behaviours and outcomes: calibration and validation in a US populationReddy KP, Bulteel AJB, Levy DE, Torola P, Hyle EP, Hou T, Osher B, Yu L, Shebl FM, Paltiel AD, Freedberg KA, Weinstein MC, Rigotti NA, Walensky RP. Novel microsimulation model of tobacco use behaviours and outcomes: calibration and validation in a US population BMJ Open 2020, 10: e032579. PMID: 32404384, PMCID: PMC7228509, DOI: 10.1136/bmjopen-2019-032579.
  • Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness Analysis.Walensky RP, Horn T, McCann NC, Freedberg KA, Paltiel AD. Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness Analysis. Annals Of Internal Medicine 2020, 172: 583-590. PMID: 32150602, PMCID: PMC7217721, DOI: 10.7326/m19-3478.
  • Has Pre-exposure Prophylaxis Made a Difference at a Population Level? Jury Is Still OutMarcus JL, Paltiel AD, Walensky RP. Has Pre-exposure Prophylaxis Made a Difference at a Population Level? Jury Is Still Out Clinical Infectious Diseases 2020, 71: 3152-3153. PMID: 32097454, PMCID: PMC7819505, DOI: 10.1093/cid/ciz1236.
  • Budget Impact of Funding an Intensive Diet and Exercise Program for Overweight and Obese Patients With Knee OsteoarthritisSmith KC, Losina E, Messier SP, Hunter DJ, Chen AT, Katz JN, Paltiel AD. Budget Impact of Funding an Intensive Diet and Exercise Program for Overweight and Obese Patients With Knee Osteoarthritis ACR Open Rheumatology 2019, 2: 26-36. PMID: 31943972, PMCID: PMC6957917, DOI: 10.1002/acr2.11090.
  • Cost‐effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysisMorozova O, Crawford FW, Cohen T, Paltiel AD, Altice FL. Cost‐effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysis Addiction 2019, 115: 437-450. PMID: 31478285, PMCID: PMC7015766, DOI: 10.1111/add.14797.
  • A Value of Information Analysis of Research on the 21-Gene Assay for Breast Cancer ManagementKunst NR, Alarid-Escudero F, Paltiel AD, Wang SY. A Value of Information Analysis of Research on the 21-Gene Assay for Breast Cancer Management Value In Health 2019, 22: 1102-1110. PMID: 31563252, PMCID: PMC7343670, DOI: 10.1016/j.jval.2019.05.004.
  • Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India’s public sectorLee DJ, Kumarasamy N, Resch SC, Sivaramakrishnan GN, Mayer KH, Tripathy S, Paltiel AD, Freedberg KA, Reddy KP. Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India’s public sector PLOS ONE 2019, 14: e0218890. PMID: 31265470, PMCID: PMC6605662, DOI: 10.1371/journal.pone.0218890.
  • Cost‐Effectiveness of Diet and Exercise for Overweight and Obese Patients With Knee OsteoarthritisLosina E, Smith KC, Paltiel AD, Collins JE, Suter LG, Hunter DJ, Katz JN, Messier SP. Cost‐Effectiveness of Diet and Exercise for Overweight and Obese Patients With Knee Osteoarthritis Arthritis Care & Research 2019, 71: 855-864. PMID: 30055077, PMCID: PMC6349519, DOI: 10.1002/acr.23716.
  • Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysisOuattara EN, MacLean RL, Danel C, Borre ED, Gabillard D, Huang M, Moh R, Paltiel AD, Eholié SP, Walensky RP, Anglaret X, Freedberg KA. Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis PLOS ONE 2019, 14: e0219068. PMID: 31247009, PMCID: PMC6597104, DOI: 10.1371/journal.pone.0219068.
  • New USPSTF Guidelines for HIV Screening and Preexposure Prophylaxis (PrEP)Walensky RP, Paltiel AD. New USPSTF Guidelines for HIV Screening and Preexposure Prophylaxis (PrEP) JAMA Network Open 2019, 2: e195042. PMID: 31184696, DOI: 10.1001/jamanetworkopen.2019.5042.
  • Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling studyBilcke J, Antillón M, Pieters Z, Kuylen E, Abboud L, Neuzil KM, Pollard AJ, Paltiel AD, Pitzer VE. Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study The Lancet Infectious Diseases 2019, 19: 728-739. PMID: 31130329, PMCID: PMC6595249, DOI: 10.1016/s1473-3099(18)30804-1.
  • THU-391-Impact of early screening and treatment of hepatitis C virus and improvements in risk reduction on HCV transmission among HIV-infected men who have sex with men in France: A modeling approachCastry M, Cousien A, Supervie V, Velter A, Ghosn J, Paltiel A, Yazdanpanah Y, Deuffic-Burban S. THU-391-Impact of early screening and treatment of hepatitis C virus and improvements in risk reduction on HCV transmission among HIV-infected men who have sex with men in France: A modeling approach Journal Of Hepatology 2019, 70: e327. DOI: 10.1016/s0618-8278(19)30639-5.
  • The Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India.Kazemian P, Costantini S, Kumarasamy N, Paltiel AD, Mayer KH, Chandhiok N, Walensky RP, Freedberg KA. The Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India. Clinical Infectious Diseases 2019, 70: 633-642. PMID: 30921454, PMCID: PMC7319272, DOI: 10.1093/cid/ciz249.
  • 2000. Rapid, Point-of-care Diagnosis of Tuberculosis with Novel Truenat Assay: Cost-Effectiveness and Budgetary Impact Analysis for India’s Public SectorLee D, Kumarasamy N, Resch S, Sivaramakrishnan G, Mayer K, Tripathy S, Paltiel A, Freedberg K, Reddy K. 2000. Rapid, Point-of-care Diagnosis of Tuberculosis with Novel Truenat Assay: Cost-Effectiveness and Budgetary Impact Analysis for India’s Public Sector Open Forum Infectious Diseases 2018, 5: s582-s582. PMCID: PMC6254532, DOI: 10.1093/ofid/ofy210.1656.
  • Bayesian adaptive algorithms for locating HIV mobile testing servicesGonsalves GS, Copple JT, Johnson T, Paltiel AD, Warren JL. Bayesian adaptive algorithms for locating HIV mobile testing services BMC Medicine 2018, 16: 155. PMID: 30173667, PMCID: PMC6120098, DOI: 10.1186/s12916-018-1129-0.
  • Cost-effectiveness of health coaching and financial incentives to promote physical activity after total knee replacementSmith KC, Paltiel AD, Yang HY, Collins JE, Katz JN, Losina E. Cost-effectiveness of health coaching and financial incentives to promote physical activity after total knee replacement Osteoarthritis And Cartilage 2018, 26: 1495-1505. PMID: 30092263, PMCID: PMC6202236, DOI: 10.1016/j.joca.2018.07.014.
  • The cost‐effectiveness and budgetary impact of a dolutegravir‐based regimen as first‐line treatment of HIV infection in IndiaZheng A, Kumarasamy N, Huang M, Paltiel AD, Mayer KH, Rewari BB, Walensky RP, Freedberg KA. The cost‐effectiveness and budgetary impact of a dolutegravir‐based regimen as first‐line treatment of HIV infection in India Journal Of The International AIDS Society 2018, 21: e25085. PMID: 29603882, PMCID: PMC5878415, DOI: 10.1002/jia2.25085.
  • The cost‐effectiveness of HIV pre‐exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in BrazilLuz PM, Osher B, Grinsztejn B, Maclean RL, Losina E, Stern ME, Struchiner CJ, Parker RA, Freedberg KA, Mesquita F, Walensky RP, Veloso VG, Paltiel AD. The cost‐effectiveness of HIV pre‐exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil Journal Of The International AIDS Society 2018, 21: e25096. PMID: 29603888, PMCID: PMC5878414, DOI: 10.1002/jia2.25096.
  • Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: a model-based evaluationLosina E, Usiskin I, Smith S, Sullivan J, Smith K, Hunter D, Messier S, Paltiel A, Katz J. Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: a model-based evaluation Osteoarthritis And Cartilage 2018, 26: 641-650. PMID: 29481917, PMCID: PMC6334297, DOI: 10.1016/j.joca.2018.02.898.
  • Lung Cancer Mortality Associated With Smoking and Smoking Cessation Among People Living With HIV in the United StatesReddy KP, Kong CY, Hyle EP, Baggett TP, Huang M, Parker RA, Paltiel AD, Losina E, Weinstein MC, Freedberg KA, Walensky RP. Lung Cancer Mortality Associated With Smoking and Smoking Cessation Among People Living With HIV in the United States JAMA Internal Medicine 2017, 177: 1613-1621. PMID: 28975270, PMCID: PMC5675744, DOI: 10.1001/jamainternmed.2017.4349.
  • The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United StatesBorre ED, Hyle EP, Paltiel AD, Neilan AM, Sax PE, Freedberg KA, Weinstein MC, Walensky RP. The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States The Journal Of Infectious Diseases 2017, 216: 798-807. PMID: 29029344, PMCID: PMC5853503, DOI: 10.1093/infdis/jix349.
  • Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid.Walensky RP, Borre ED, Bekker LG, Hyle EP, Gonsalves GS, Wood R, Eholié SP, Weinstein MC, Anglaret X, Freedberg KA, Paltiel AD. Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid. Annals Of Internal Medicine 2017, 167: 618-629. PMID: 28847013, PMCID: PMC5675810, DOI: 10.7326/m17-1358.
  • A Flow-Based Model of the HIV Care Continuum in the United StatesGonsalves GS, Paltiel AD, Cleary PD, Gill MJ, Kitahata MM, Rebeiro PF, Silverberg MJ, Horberg M, Abraham AG, Althoff KN, Moore R, Bosch RJ, Tang T, Hall HI, Kaplan EH. A Flow-Based Model of the HIV Care Continuum in the United States JAIDS Journal Of Acquired Immune Deficiency Syndromes 2017, 75: 548-553. PMID: 28471841, PMCID: PMC5533168, DOI: 10.1097/qai.0000000000001429.
  • The Inclusion Body Myositis Registry at Yale: A growing information database and practical tool for researchers, clinicians, and patientsCotzomi E, Petschke K, O'Connor K, Paltiel A. The Inclusion Body Myositis Registry at Yale: A growing information database and practical tool for researchers, clinicians, and patients Muscle & Nerve 2017 DOI: 10.1002/mus.25774.
  • An Adaptive Approach to Locating Mobile HIV Testing ServicesGonsalves GS, Crawford FW, Cleary PD, Kaplan EH, Paltiel AD. An Adaptive Approach to Locating Mobile HIV Testing Services Medical Decision Making 2017, 38: 262-272. PMID: 28699382, PMCID: PMC5748375, DOI: 10.1177/0272989x17716431.
  • Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settingsAntillón M, Bilcke J, Paltiel AD, Pitzer VE. Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings Vaccine 2017, 35: 3506-3514. PMID: 28527687, PMCID: PMC5462484, DOI: 10.1016/j.vaccine.2017.05.001.
  • Setting Performance Standards for a Cost-Effective HIV Cure Strategy in South AfricaStandards for HIV Cure in South AfricaPaltiel AD, Zheng A, Weinstein MC, Gaynes MR, Wood R, Freedberg KA, Sax PE, Walensky RP. Setting Performance Standards for a Cost-Effective HIV Cure Strategy in South AfricaStandards for HIV Cure in South Africa Open Forum Infectious Diseases 2017, 4: ofx081. PMID: 28680903, PMCID: PMC5490502, DOI: 10.1093/ofid/ofx081.
  • Cost‐Effectiveness of Tramadol and Oxycodone in the Treatment of Knee OsteoarthritisSmith SR, Katz JN, Collins JE, Solomon DH, Jordan JM, Suter LG, Yelin EH, Paltiel AD, Losina E. Cost‐Effectiveness of Tramadol and Oxycodone in the Treatment of Knee Osteoarthritis Arthritis Care & Research 2016, 69: 234-242. PMID: 27111538, PMCID: PMC5378156, DOI: 10.1002/acr.22916.
  • Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South AfricaGilbert JA, Shenoi SV, Moll AP, Friedland GH, Paltiel AD, Galvani AP. Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa PLOS ONE 2016, 11: e0165614. PMID: 27906986, PMCID: PMC5131994, DOI: 10.1371/journal.pone.0165614.
  • Optimal frequency of rabies vaccination campaigns in Sub-Saharan AfricaBilinski AM, Fitzpatrick MC, Rupprecht CE, Paltiel AD, Galvani AP. Optimal frequency of rabies vaccination campaigns in Sub-Saharan Africa Proceedings Of The Royal Society B 2016, 283: 20161211. PMID: 27852799, PMCID: PMC5124087, DOI: 10.1098/rspb.2016.1211.
  • Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling StudyReddy KP, Parker RA, Losina E, Baggett TP, Paltiel AD, Rigotti NA, Weinstein MC, Freedberg KA, Walensky RP. Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study The Journal Of Infectious Diseases 2016, 214: 1672-1681. PMID: 27815384, PMCID: PMC5144729, DOI: 10.1093/infdis/jiw430.
  • Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South AfricaEricsen A, Lauck M, Mohns M, Dinapoli S, Mutschler J, Greene J, Weinfurter J, Lehrer‐Brey G, Crosno K, Peterson E, Reynolds M, Wiseman R, Burwitz B, Sacha J, Friedrich T, Brenchley J, O'Connor D, Xu C, He T, Haret‐Richter G, Franck D, Policicchio B, Brocca‐Cofano E, Ma D, Stock J, Tracy R, Landay A, Wilson C, Apetrei C, Pandrea I, Wong E, Xulu B, Prakadan S, Shalek A, Lalloo U, Baijnath P, Suleman M, Moodley V, Mitha M, Maharaj P, Costiniuk C, Nielsen M, Mhlane Z, Karim F, Lewinsohn D, Ndung'u T, Pasternak A, Prins J, Berkhout B, Leon‐Fuentes L, Viveros‐Rogel M, Vergara‐Mendoza M, Rodriguez‐Castañón M, Cardenas‐Ochoa A, Tello‐Mercado A, Vega C, Sierra‐Madero J, Soto‐Ramirez L, Perez‐Patrigeon S, Hensley‐Mcbain T, Cheu R, Manuzak J, Zevin A, Miller C, Lee E, Wilson C, Burgener A, Klatt N, Mellins C, Abrams E, Dolezal C, Warne P, Elkington K, Bucek A, Leu C, Maskew M, Bor J, MacLeod W, Carmona S, Sherman G, Fox M, Judd A, Chappell E, Doerholt K, Galli L, Giaquinto C, Gibb D, Goetghebuer T, Le Coeur S, Julian A, Turkova A, Goodall R, Collaboration E, Davies M, Sawry S, Phiri S, Rabie H, Eley B, Fatti G, Technau K, Tanser F, Wood R, Giddy J, Bolton‐Moore C, Chimbetete C, Hazra R, Keiser O, Stinson K, Collins I, Team C, Cluver L, Toska E, Orkin M, Yakubovich A, Hodes R, Sherr L, Decroo T, Telfer B, Dores C, Candrinho B, Dos Santos N, Mkwamba A, Dezembro S, Jofrisse M, Ellman T, Metcalf C, Hanrahan C, Keyser V, Schwartz S, Soyizwaphi P, West N, Mutunga L, Steingo J, Bassett J, Van Rie A, Abongomera G, Cook A, Lamorde M, Chabala C, Musiime V, Thomason M, Mulenga V, Colebunders R, Kityo C, Walker S, Gibb D, Team O, Fox M, Bor J, MacLeod W, Maskew M, Brennan A, Stevens W, Carmona S, Brocca‐Cofano E, Xu C, Ma D, Policicchio B, Raehtz K, Dunsmore T, Haret‐Richter G, Sykes C, Keele B, Kashuba, Pandrea I, Apetrei C, Gulick R, Wilkin T, Chen Y, Landovitz R, Amico R, Young A, Richardson P, Marzinke M, Hendrix C, Eshleman S, McGowan I, Andrade A, Hodder S, Klingman K, Chege W, Rinehart A, Rooney J, Andrew P, McCauley M, Mayer K, Team H, McGowan I, Siegel A, Engstrom J, Nikiforov A, Duffill K, Edick S, Mitchell C, Back D, Else L, Egan D, Khoo S, Williams P, Brand R, Cranston R, Grant R, Fonner V, Rodolph M, Liegler T, Glidden D, Baggaley R, Brown E, Palanee‐Philips T, Marzinke M, Hendrix C, Dezutti C, Soto‐Torres L, Baeten J, Kharsany A, Cawood C, Khanyile D, Grobler A, Puren A, Kufa‐Chakeza T, Samsunder N, Frohlich J, Karim Q, George G, Govender K, Toledo C, Chipeta Z, Zembe L, Glenshaw M, Madurai L, Bere A, Deyde V, Riche B, Maman D, Wanjala S, Mendiharat P, Hennequin W, Vandenbulcke A, Mukui I, Subtil F, Ecochard R, Marty L, Cazein F, Pillonel J, Costagliola D, Supervie V, Nelson R, Thompson R, Casavant I, Pals S, Bonzela J, Mugabe D, Come J, Ujamaa D, Cardoso J, Auld A, Maculuve B, Wei S, Shodell D, MacKellar D, Bor J, Brennan A, Fox M, Maskew M, Stevens W, Carmona S, MacLeod W, Logie C, Daniel C, Wang Y, Bozinoff N, Fast D, Long C, Kerr T, Small W, Pannetier J, Ravalihasy A, Le Guen M, Lydié N, Dray‐Spira R, Bajos N, Lert F, du Lou A, Group P, Kuo C, Operario D, Hoare J, Underhill K, Giovenco D, Atujuna M, Mathews C, Stein D, Brown L, Hecht J, Plenty A, Lin J, Charlebois E, Igonya E, Ndimbii J, Guise A, Owiti F, Rhodes T, Strathde S, Deuba K, Anderson S, Ekström A, Pandey, Shrestha R, Karki D, Marrone G, Lyons C, Diouf D, Drame F, Kouamé A, Ezouatchi R, Bamba A, Thiam M, Liestman B, Ketende S, Baral S, Gibbs A, Dunkle K, Khumalo T, Ntini N, Washington L, Mbatha N, Chirwa E, Willan S, Sikweyiya Y, Jama‐Shai N, Jewkes R, Groves A, Reyes H, Moodley D, Maman S, Bukowski L, Coulter R, Riley N, Buehler S, Hoffmann C, Gehr‐Seloover A, Team R, Faden R, Gilbert S, Sullivan K, Cadigan J, Krubiner C, Namey E, Little M, Lyerly A, Mastroianni A, Rao A, Baral S, Phaswana‐Mafuya N, Lambert A, Kose Z, McIngana M, Holland C, Ketende S, Schwartz S, Masvawure T, Lafort Y, Chabeda S, Restar A, Gichangi P, Tocco J, Sandfort T, Mantell J, Tam A, Tumwekwase G, Kabunga E, Russell S, Seeley J, Li C, Zhao Y, Zhang H, Cheng Z, Hong P, Liang X, Gaoshan J, Li L, Tang K, Carrasco M, Kennedy C, Barrington C, Perez M, Donastorg Y, Kerrigan D, Hartson K, Sherman D, Mofelehetsi S, Ncheke T, Khasoane M, Wong J, Fung K, Hui C, Luyombya H, Bisignano A, Maitland D, Poon K, Li A, Perez‐Brumer A, McLean S, Silva‐Santisteban A, Huerta L, de la Grecca R, Mayer K, Sanchez J, Lama, Reisner S, Bonnington O, Wamoyi J, Ddaaki W, Bukenya D, Odongo F, Skovdal M, McLean E, Nyamukapa C, Moshabela M, Wringe A, Chapman S, Chihana N, Scheepers E, Schmitz K, Joseph J, Suggu K, Hariharan N, Esiru G, Yavuz E, Gross J, Mirembe B, Sherr K, Rustagi A, Gimbel S, Nduati R, Cuembelo F, Kone A, Farquhar C, Wasserheit J, Gloyd S, de Schacht C, Team S, Kamanga E, Banda G, Mofolo I, Mwale G, Mwale M, Chikonda J, Sherman J, Chinkonde J, Herce M, Ng'oma K, Mtileni T, Odongo I, Robinson P, Mogashoa M, Bhardwaj S, Holele P, Pillay Y, Goga A, Jackson D, Lombard C, Ramokolo V, Ngandu N, Sherman G, Puren A, Doherty T, Bhardwaj S, Noveve N, Ramraj T, Magasana V, Singh Y, Pillay Y, Group S, Kroon E, Ananworanich J, Eubanks K, Intasan J, Pinyakorn S, Chomont N, Lewin, Palmer S, Trautmann L, Yang H, Chomchey N, Phanuphak N, Cooper K, Phanuphak P, de Souza M, group O, Bekker L, Laher F, Moodie Z, Tomaras G, Grunenberg N, Allen M, Daniels B, Innes C, Mngadi K, Malahleha M, Gilbert P, Michael N, Phogat S, Granados C, Kanesa‐Thasan N, Corey L, Gray G, McElrath J, Team T, Cowan F, Davey C, Mushati P, Mtetwa S, Chiyaka T, Chabata S, Fearon E, Mavedzenge S, Cambiano V, Masuka N, Chemhuru M, Dirawo J, Hanisch D, Hatzold K, Mugurungi O, Busza J, Phillips A, Hargreaves J, Hosek S, Landovitz R, Rudy B, Kapogiannis B, Siberry G, Rutledge B, Liu N, Brothers J, Rooney J, Wilson C, Interventions T, Mera R, McCallister S, Palmer B, Mayer G, Magnuson D, Rawlings K, Stieh D, Matias E, Fought A, Marx P, Veazey R, Hope T, Ngcapu S, Carias A, Liebenberg L, Werner L, Cianci G, McRaven M, Sibeko S, Garrett N, Kriek J, McKinnon L, Karim S, Karim Q, Passmore J, Hope T, Raehtz K, Haret‐Richter G, Xu C, Policicchio B, Barrenas C, Ma D, Wijewardana V, Brocca‐Cofano E, Stock J, Trichel A, Keele B, Estes J, Katze M, Pandrea I, Apetrei C, Ndhlovu Z, Nkosi T, Mewalal N, Ismail N, Moodley A, Dong K, Ndun'gu T, Walker B, Martin G, Pantazis N, Hoffmann M, Hickling S, Hurst J, Meyerowitz J, Willberg C, Robinson N, Brown H, Fisher M, Kinloch S, Babiker A, Weber J, Nwokolo N, Fox J, Fidler S, Phillips R, Frater J, Investigators S, van den Berg K, Vermeulen M, Xulu T, McClure C, Ingram C, Beck G, Stone M, Busch M, Custer B, Murphy E, Study N, Garrett N, Norman E, Asari V, Naicker N, Majola N, Leask K, Karim Q, Karim S, Onoya D, Sineke T, Brennan A, Fox M, Datong P, Jaspan H, Osawe S, Gatei J, Coombs J, Muldoon K, Mallick R, Gray C, Rosenthal K, Cameron D, Abimiku A, Zash R, Souda S, Leidner J, Binda K, Hick C, Powis K, Makhema J, Mmalane M, Essex M, Lockman S, Shapiro R, Jao J, Kacanek D, Williams P, Geffner M, Livingston E, Sperling R, Patel K, Bardeguez A, Burchett S, Chakhtoura N, Scott G, Van Dyke R, Abrams E, Network P, Narendran G, Kumar S, Padmapriyadarsini C, Gomathi N, Menon P, Sekar L, Reddy S, Chandra S, Kumar A, Kumar S, Sekar S, Ravichandran N, Raja K, Lavanya J, Sridhar R, Lakshmi M, Mahilmaran A, Swaminathan S, Atuhumuza E, Yoon C, Katende J, Asege L, Mwebe S, Andama A, Armstrong D, Dowdy D, Kamya M, Semitala F, Cattamanchi A, Ward A, Barr D, Schutz C, Burton R, Boulle A, Maartens G, Wilkinson R, Meintjes G, Flick R, Simon K, Munthali A, Dimba A, Kim M, Kazembe P, Hosseinipour M, Ahmed S, Merle C, Floyd S, Ndiaye A, Galperine T, Furco A, De Jong B, McIlleron H, Glynn J, Sarr M, Bah‐sow O, Affolabi D, Team O, Bräu N, Wyles D, Kottilil S, Darr E, Workowski K, Luetkemeyer A, Adeyemi O, Ruane P, Doehle B, Huang K, Osinusi A, McNally J, Natha M, Guion M, McLean T, Brainard D, McHutchison J, Naggie S, Sulkowski M, Mogalian E, Luetkemeyer A, Naik S, Natha M, Stamm L, Osinusi A, Shen G, Sajwani K, McNally J, Mathias A, Kouamé, Moh R, Boyd A, Badjé A, Gabillard D, N'takpé J, Maylin S, Eholié S, Anglaret X, Danel C, Group A, Rockstroh J, Orkin C, Viani R, Wyles D, Luetkemeyer A, Lazzarin A, Soto‐Malave R, Nelson M, Bhagani, Klinker H, Rizzardini G, Girard P, Shulman N, Hu Y, Fredrick L, Trinh R, Gane E, Kourtis A, Wang L, Wiener J, Liang S, Wei X, Liu W, Chen L, Shepard C, Wang A, Zhang F, Bulterys M, Group T, Molina J, Charreau I, Spire B, Cotte L, Chas J, Capitant C, Tremblay C, Rojas‐Castro D, Cua E, Pasquet A, Bernaud C, Rozenbaum W, Delaugerre C, Doré V, Le Mestre S, Simon M, Delfraissy J, Meyer L, Group A, Hucks‐Ortiz C, Lucas J, Wheeler D, Fields S, Caucus T, Wheeler D, Fields S, Nelson L, Hightow‐Weidman L, Magnus M, Shoptaw S, Beauchamp G, Emel L, Piwowar‐Manning E, Chen Y, Watkins P, Mayer K, Team H, Baeten J, Heffron R, Kidoguchi L, Mugo N, Katabira E, Bukusi E, Asiimwe S, Morton J, Ngure K, Bulya N, Odoyo J, Tindimwemba E, Haberer J, Marzinke M, Donnell D, Celum C, Petersen M, Balzer L, Kwarsiima D, Sang N, Chamie G, Ayieko J, Kabami J, Owaraganise A, Liegler T, Mwangwa F, Kadede K, Jain V, Plenty A, Lavoy G, Black D, Bukusi E, Cohen C, Clark T, Charlebois E, Kamya M, Havlir D, Team S, Radix A, Carneiro P, Stephanos S, Mosher S, Meacher P, Belkind U, Evans‐Frantz I, Brigham F, Fortenberry A, Comstock L, Vail R, Weiss S, Pena S, Golub S, Garofalo R, Kuhns L, Reisner S, Biello K, Mimiaga M, Bukowski L, Meanley S, Egan J, Matthews D, Stall R, Team T, Bauer G, Shokoohi M, Hammond R, Scheim A, Slogrove A, Judd A, Leroy V, Collaboration C, Naidoo S, Sartorius B, de Vries H, Taylor M, Pettifor A, Wang J, Selin A, Hughes J, Gómez‐Olivé X, Wagner R, MacPhail C, Kahn K, Team H, Kann L, Olsen E, McManus T, Zaza S, Mulligan K, Hosek S, Kapogiannis, Landovitz R, Liu N, Cofield S, Perumean‐Chaney, Havens P, Rutledge B, Wilson C, Team A, Marshall B, Tate J, McGinnis K, Fiellin D, Bryant K, Justice A, Springer S, Azar M, Barbour R, Krishnan A, Altice F, DiPaola A, Baghazal A, Tariko L, Shikely K, Patta S, Omar B, Musyoki H, Bertrand S, Abdallah S, Stone J, Brooks‐Pollock E, Altice F, Azbel L, Smyrnov P, Martin N, Vickerman P, Borquez A, Abramovitz D, Beletsky L, Vickerman P, Gonzales‐Zuñiga P, Rangel G, Hickman M, Strathdee, Martin N, Wall K, Kilembe W, Vwalika B, Haddad L, Khu N, Brill I, Vwalika C, Chomba E, Tichacek A, Allen S, Darbes L, McGrath N, Johnson M, Hosegood V, Fritz K, Ngubane T, van Rooyen H, Ruark A, Brewster‐Lee D, Hembling J, Davis V, Renju J, Wringe A, Crampin A, Koole O, Nyirenda C, Namadingo H, McLean E, Network A, Li L, Liang L, Lin C, Xiao Y, Ji G, Irani L, McGinn E, Mellish M, Mtema O, Dindi P, Imakit R, Ajok S, Talima D, Namakula A, Allen H, Fair C, Trexler C, D'Angelo L, Stadler J, Chikandiwa A, Mayaud P, Rees H, Imrie J, Delany‐Moretlwe S, Taylor T, Oberth G, Mumba O, Bhayani L, Russell A, Mwanza F, Milanga M, Nandelenga R, Namutamba D, Albert‐Hope C, Gustav R, Simon Y, Castellanos E, Irwin R, Holloway I, Steward W, Mortimer J, Curtis P, Van Gorder D, Leibowitz A, Morin S, Mulhern‐Pearson C, Donnelly A, King A, Fox A, Pulsipher C, Evans D, Lemp G, Baral S, Lyons C, Sullivan E, Kurani S, Sherwood J, Millett G, MacAllister J, Zanolini A, Chipungu J, Bosomprah S, Mafwenko M, Holmes C, Thirumurthy H, Qin Y, Liu F, Tang W, Tang S, Liu C, Mao J, Zhang W, Taege A, Nowacki A, Wei C, Tucker J, Madanhire C, Sibanda E, Ruhode N, Hatzold K, Cowan F, Mavedzenge, Manjezi N, Fatti G, Mothibi E, Shaikh N, Oyebanji O, Grimwood A, Sibanda E, Tumushime M, Mufuka J, Gudukeya S, Mavedzenge S, Bautista‐Arredondo S, Thirumurthy H, McCoy S, Padian N, Hatzold K, Copas A, Cowan F, Dougherty G, Clarke K, Fayorsey R, Kamonga M, Kimambo S, Lutkam D, Madevu‐Matson C, Mtiro H, Msuka S, Mugisha V, Panya M, Ramadhani A, Sipemba J, Urasa P, Rabkin M, Granich R, Gupta S, Hall I, Aberle‐Grasse J, Hader S, Mermin J, Koenig S, Dorvil N, Severe P, Riviere C, Faustin M, Perodin C, Paul C, Apollon A, Saintil G, Duverger L, Dumont E, Hedt‐Gauthier B, Hennessey K, Rivera V, Devieux J, Pape J, Kitheka M, Curran K, Gathii P, Mudany M, Bii S, Bor J, Ahmed S, Fox M, Rosen S, Katz I, Tanser F, Pillay D, Bärnighausen T, MacKellar D, Maruyama H, Weber R, Ernest O, Porter S, Gikaro J, Alexander G, Kundi G, Byrd J, Kazaura K, Mbilinyi D, Morales F, Justman J, Josiah R, McNairy M, Lamb M, Gachuhi A, Nuwagaba‐Biribonwoha H, Burke S, Mazibuko S, Okello V, Ehrenkranz P, Sahabo R, El‐Sadr W, Group L, Dhodho M, Frieden M, Shroufi A, Wanjiru E, Daho S, Simons E, Bygrave H, Giuliani R, Torrens A, Molfino L, Silva C, Ellman T, Magaia A, van Dijk J, Kamenova K, Shamu A, Pfeiffer K, Hobbins M, Ehmer J, Murungu J, Barnabas R, Coombs R, Chang M, Schaafsma T, Asiimwe S, Thomas K, Baeten J, Celum C, Moyo S, Mohammed T, Wirth K, Bennett K, Holme M, Mupfumi L, Sebogodi P, Moraka N, Boleo C, Maphorisa C, Seraise B, Gaseitsiwe S, Musonda R, van Widenfelt E, Powis K, Gaolathe T, Tchetgen E, Makhema J, Essex M, Lockman S, Novitsky V, Brigstock‐Barron O, Logan L, Sowerbutts H, Womack V, Osman M, Anderson J, Nardone A, Pinkevych M, Reynaldi A, Fennessey C, Reid C, Nadella P, Lipkey L, Newman L, Ayala V, Jain S, Del Prete G, Estes J, Ott D, Lifson J, Ohlen C, Keele B, Davenport M, Kaminski R, Hu W, Karn J, Khalili K, Peterson C, Wang J, Polacino P, Hu S, Holmes M, Kiem H, Bozzi G, Watters S, Simonetti F, Anderson E, Gorelick R, Shao W, Bell J, Rehm C, Dewar R, Yarchoan R, Uldrick T, Maldarelli F, Wensing A, Diez‐Martin J, Huetter G, Kuball J, Kwon M, Nijhuis M, Saez‐Cirion A, Rocha V, Salgado M, Wiesch J, Stam A, Martinez‐Picado J, Huang L, Lai W, Zhu L, Chen C, Felber B, Hu X, Valentin A, Dayton F, Cai Y, Rosati M, Alicea C, Sardesai N, Gautam R, Martin M, Mullins J, Pavlakis G, Koofhethile C, Ndhlovu Z, Thobakgale C, Prado J, Ismail N, Mncube Z, Mkhize L, van der Stok M, Yende N, Walker B, Goulder P, Ndung'u T, Cohort S, Worley M, Kelleher A, Kent S, Chung A, Okala S, King D, Shattock R, He T, Policicchio B, Brocca‐Cofano E, Stock J, Xu C, Raehtz K, Gaufin T, Gautam R, Pandrea I, Apetrei C, Mylvaganam G, Hicks S, Lawson B, Nega M, Velu V, Ahmed R, Freeman G, Amara R, Steele S, Arellano G, Ellman T, Shroufi A, Van Cutsem G, Oldenburg C, Bor J, Tanser F, Mutevedzi T, Shahmanesh M, Seage G, De Gruttola V, Mimiaga M, Mayer K, Pillay D, Bärnighausen T, Currier J, Britto P, Hoffman R, Brummel S, Masheto G, Joao E, Santos B, Aurpibul L, Losso M, Pierre M, Weinberg A, Chakhtoura N, Browning R, Coletti A, Shapiro D, Pilotto J, Team P, Munderi P, Were E, Avihingsanon A, Mbida P, Mohapi L, Samba B, Jansen M, Mohammed P, Sawyerr G, Barnes P, van Delft Y, Odongpiny E, Nalwanga D, Kaimal A, Kiragga A, Nabaggala S, Castelnuovo B, Parkes‐Ratanshi R, Stranix‐Chibanda L, Brummel S, Angelidou K, Tierney C, Coletti A, McCarthy K, Pilotto J, Mutambanengwe M, Chanaiwa V, Mhembere T, Kamateeka M, Masheto G, Chamanga R, Maluwa M, Hanley S, Joao E, Theron G, Chandawale A, Nyathi M, Santos B, Aurpibul L, Mubiana‐Mbewe M, Oliveira R, Basar M, Chakhtoura N, Browning R, Currier J, Fowler, Team P, Molina J, Grund B, Gordin F, Williams I, Schechter M, Losso M, Law M, Ekong E, Mwelase N, Skoutelis A, Wiselka M, Vanderkerckhove L, Benfield T, Munroe D, Lundgren J, Group J, Arenas‐Pinto A, Grund B, Sharma S, Martinez E, Cummins N, Fox J, Klingman K, Sedlacek D, Collins S, Flynn P, Chasanov, Kedem E, Katlama C, Sierra‐Madero J, Ormaasen V, Brouwers P, Cooper D, Group F, Lake J, Trottier B, Garcia‐Diaz J, Edelstein H, Kumar P, Bredeek U, Loutfy M, Brennan C, Koteff J, Wynne B, Hopking J, Aboud M, Kerrigan D, Mantsios A, Margolis D, Murray M, Orrell C, Hagins D, Belonosova E, Porteiro N, Walmsley S, Falcó V, Man C, Aylott A, Buchanan A, Wynne B, Vavro C, Aboud M, Smith K, Margolis D, Podzamczer D, Stellbrink H, Lutz T, Angel J, Richmond G, Clotet B, Gutierrez F, Sloan L, Griffith S, St Clair M, Dorey D, Ford S, Mrus J, Crauwels H, Smith K, Williams P, Spreen W, Bavinton B, Phanuphak N, Jin F, Zablotska I, Grinsztejn B, Prestage G, Grulich A, Group O, Couderc C, Keita B, Anoma C, Wade A, Ouédraogo A, Coulibaly A, Ehouman S, Diop A, Somda M, Yomb Y, Henry E, Spire B, Laurent C, Mendizabal‐Burastero R, Galindo‐Arandi C, Yancor M, Vela I, Aguilar‐Martinez J, Paz‐Bailey G, Hoots B, Xia M, Finlayson T, Prejean J, Purcell D, Group F, Hightow‐Weidman L, Magnus M, Beauchamp G, Hurt C, Shoptaw S, Emel L, Piwowar‐Manning E, Mayer K, Nelson L, Wilton L, Watkins P, Fields S, Wheeler D, Tong C, Suzan‐Monti M, Sagaon‐Teyssier L, Ossanga O, Laurent C, Maradan G, Ambani A, Vidal L, Spire B, Boyer S, Group E, Phillip R, Mudzviti T, Shamu T, Chimbetete C, Rakhmanina N, Corrigan B, Kose J, Manson K, Collaborative N, Cawley C, Oti S, Njamwea B, Nyaguara A, Odhiambo F, Otieno F, Njage M, Shoham T, Church K, Todd J, Zaba B, Wringe A, Network A, Bivol S, Catranji V, Caraulan L, Lucas J, Karuna S, Hinson K, Sista N, Yola N, Ntombela F, Mgodi N, Luthuli N, Wakefield S, Andrew P, Greene E, Delany‐Moretlwe S, Gray G, White R, McCoy S, Njau P, Fahey C, Czaicki N, Kapologwe N, Kadiyala S, Dow W, Jewell N, Padian N, Jagessar N, Papua L, Ndunda E, Wijne M, Hendriks S, Khoza N, Stadler J, MacPhail C, Chikandiwa A, Brahmbhatt H, Delany‐Moretlwe S, Toska E, Cluver L, Boyes M, Isaacsohn M, Hodes R, Sherr L, Study M, Bermudez L, Jennings L, Ssewamala F, Nabunya P, Mellins C, McKay M, Fagan T, Zulu C, Zeng W, Menon V, Korenromp E, Haacker M, Turay M, Rotich K, Strauss M, Barihuta T, Semini I, Stover J, Nitschke A, Forster N, Poku N, Dutta A, Barker C, Lazar L, Grosso A, Millett G, Honermann B, Sherwood J, MacAllister J, Lindsey K, Chandra C, Blumenthal S, Lyons C, Baral S, Donaldson E, Mattur D, Fisher K, Harmon T, Harrison P, Izazola‐Licea J, Naeveke A, Warren M, Irani L, McGinn E, Mellish M, Mtema O, Dindi P, Faye S, Johns B, Baruwa E, Ambrose K, Bassett I, Hong T, Drain P, Govere S, Thulare H, Krows M, Moosa M, Mhlongo B, Wexler D, Huang M, Frank S, Hyle E, Parker R, Mukuye A, Lukoda N, Crandall B, Bryant H, Oliveras E, Colua E, Marinda E, Campbell, Gustafson K, Jalan P, Ngauv B, Sovannarith S, Wilhelm A, Sopheap S, Vichea C, Middlecote C, Sun L, Kgwaadira B, Katlholo T, Fiebig L, Boyd R, Wame M, Kuate L, Agegnehu D, Dikobe W, Sangrujee N, Petlo C, Nkomo B, Avalos A, Skiles M, Phillips H, Wuhib T, Finlay‐Vickers A, Stegman P, Kripke K, Njeuhmeli E, Samuelson J, Schnure M, Dalal S, Farley T, Hankins C, Thomas A, Reed J, Bock N, Durand‐Zaleski I, Mutuon P, Charreau I, Temblay C, Rojas D, Chas J, Chidiac C, Capitant C, Spire B, Meyer L, Molina J, Ipergay A, Luz P, Osher B, Grinsztejn B, MacLean R, Losina E, Struchiner C, Parker R, Freedberg K, Mesquita F, Walensky R, Veloso V, Paltiel A, Shiino T, Hattori J, Sadamasu K, Nagashima M, Hachiya A, Sugiura W, Yoshimura K, Network T, Villaran M, Brezak A, Ahmed S, Ulrich A, Duerr A, Herbeck J, Mullins J, Seto E, Morgan E, Nyaku A, D'Aquila R, Schneider J, de Oliveira T, Khumalo P, Cawood C, Dellar R, Tanser F, Hunt G, Grobler A, Kharsany A, Madurai L, Karim Q, Karim S, Hora B, Gulzar N, Chen Y, Cai F, Su C, Karagiannis K, Smith K, Simonyan V, Shah, Ahmed M, Sanchez A, Stone M, Cohen, Haynes B, Busch M, Mazumder R, Denny T, Gao F, Hakim J, Musiime V, Szubert A, Siika A, Mallewa J, Agutu C, Pett S, Bwakura‐Dangarembizi M, Lugemwa A, Kaunda S, Karoney M, Maitland K, Griffiths A, Kityo C, Mugyenyi P, Prendergast A, Walker A, Gibb D, Team R, Kityo C, Siika A, Szubert A, Mallewa J, Bwakura‐Dangarembizi M, Kabahenda S, Mwaringa S, Pett S, Griffiths A, Lugemwa A, Wachira S, Musoro G, Rajapakse C, Etyang T, Abach J, Wavamunno P, Nyondo‐Mipando L, Reid A, Nathoo K, Hakim J, Gibb D, Walker A, team R, Cahn P, Kaplan R, Sax P, Squires K, Molina J, Avihingsanon A, Ratanasuwan W, Rojas E, Rassool M, Xu X, Rodgers A, Rawlins S, Nguyen B, Leavitt R, Teppler H, Group F, Cahn P, Rolón M, Figueroa M, Gun A, Patterson P, Sued O, Patel V, Rawat S, Lelutiu‐Weinberger C, Dange A, Kamath C, Poojary R, Bisht M, Golub, Jamil, Prestage G, Fairley C, Grulich A, Smith K, Chen M, Holt M, McNulty A, Bavinton B, Conway D, Wand H, Keen P, Bradley J, Kolstee J, Batrouney C, Russell D, Law M, Kaldor J, Guy R, Shenoi S, Moll A, Madi J, Guddera V, Madondo T, Turner D, Brooks R, Kyriakides T, Andrews L, Friedland G, Thirumurthy H, Masters S, Obonyo B, Mavedzenge S, Maman S, Omanga E, Agot K, Iwuji C, Orne‐Gliemann J, Balestre E, Larmarange J, Thiebaut R, Tanser F, Okesola N, Makowa T, Dreyer J, Herbst K, Grath N, Barnighausen T, Boyer S, De Oliveira T, Rekacewicz C, Bazin B, Newell M, Pillay D, Dabis F, Group F, Bernard E, Eba P, Kazatchkine C, Müller A, Daskilewicz K, Spencer S, Meer T, Artz L, Saha A, Grant C, Patel P, Getahun M, Sellers T, Ndeogo T, Blantari J, Awotwi E, Saunders P, Outlaw S, Demeri D, McCracken J, Hagos K, King C, Shubert V, Daskalakis D, Tietz D, Harrington M, Smith K, Ferrusi C, Kavanagh M, Bhardwaj K, Tomlinson C, Hu Y, Waterhouse C, Rutter L, Amin T, Radhakrishnan P, Mellouk O, Di Giano L, Babikhina K, Golovin S, Fonseca E, Bastos F, Siegler A, Liu A, Mayer K, Thure K, Fish R, Andrew E, Gelman M, Sullivan P, Mansoor L, Karim Q, Mngadi K, Montague C, Yende‐Zuma N, Dawood H, Gengiah T, Samsunder N, Baxter C, Schwartz J, Doncel G, Ntombela F, Grobler A, Karim S, Wyatt M, Pisarski E, Tam M, Nakku‐Joloba E, Muwonge T, Katabira E, Ware N, Gibson S, Crouch P, Hecht J, Gagliano J, Patriarca T, Auerbach J, Grant R, Lyon W, Hall C, Zablotska I, Grulich A, Guy R, Amin J, Selvey C, Schmidt H, Price K, Cooper D, Group E, Mugwanya K, Heffron R, Wyatt C, Mugo N, Celum C, Kiarie J, Katabira E, Ronald A, Baeten J, Teams F, Cawley C, Nicholas S, Szumilin E, Perry S, Quiles I, Masiku C, Wringe A, Jefferys L, Hector J, Hobbins M, Ehmer J, Anderegg N, Shade S, Chang W, Kahn J, Mwai D, Mwangwa F, Kwarisiima D, Owaraganise A, Ayieko J, Havlir D, Kamya, Charlebois E, Petersen M, Clark T, Bukusi E, Cohen C, Jain V, Pasipamire L, Kerschberger B, Zabsonre I, Ndlovu S, Sibanda G, Mamba S, Mazibuko S, Lukhele N, Kabore S, Rusch B, Jakubowski A, Kabami J, Mwai D, Snyman K, Clark T, Ayieko J, Owaraganise A, Mwangwa F, Petersen M, Cohen C, Bukusi E, Kamya M, Havlir D, Charlebois E, Thirumurthy H, Nofemela A, Kalombo C, Orrell C, Myer L, Ngandu N, Carlson J, Chopera D, Ndabambi N, Goodier S, Garrett N, Samsunder N, Karim Q, Karim S, Williamson C, Rolland M, Tovanabutra S, Kijak G, Sanders‐Buell E, Bose M, Owen C, Maganga L, Nitayaphan S, Rono K, Sekiziyivu A, Eller L, Kim J, Michael N, Robb M, Palmer B, Neff C, Li S, Schneider J, Campbell T, Lozupone C, Byrne E, Anahtar M, Cohen K, Moodeley A, Padavattan N, Ismail N, Bowman B, Olson G, Mabhula A, Leslie A, Ndung'u T, Walker B, Ghebremichael, Dong K, Kwon D, Liebenberg L, McKinnon L, Leask K, Rositch A, Garrett N, Samsunder N, Kharsany A, Grobler A, Singh A, Passmore J, Karim S, Karim Q, Martinez S, Campa A, Huffman F, Makhema J, Moyo S, Williams O, Marlink R, Baum M, Mutenda N, Nakanyala T, Hamunime N, Mekonen T, Tjituka F, Natanael S, Mazibuko G, Mwinga S, Mabirizi D, Sagwa E, Walkowiak H, Kiesling A, Aptekar S, Jordan M, Hong S, Zapiola I, Cecchini D, Giuliano S, Martinez M, Rodriguez C, Bouzas M, Dzissyuk N, Abishev A, Zhanpeisova A, Nagashbekova G, Tazhibayeva G, Schramm B, Carnimeo V, Rakesh A, Ardiet D, Cossa L, Bouchaud O, Alloui C, Oo W, Dias P, Mukui I, Omwoyo W, Manuel R, de Pedro A, Telnov A, Chirwa Z, Chilima B, Nicholas S, Vubil A, Serrano L, Opolo V, Zeh C, Peeters M, Molfino L, Salumu L, Vandenbulcke A, Amoros I, Etard J, Rodríguez M, Balkan S, Szumilin E, Thompson J, Kityo C, Walker A, Hakim J, Kambugu A, van Oosterhout J, Siika A, Mweemba A, Van den Eede P, Dunn D, Paton N, Team F, Díaz A, Casado J, Dronda F, Gómez‐Ayerbe C, Vivancos M, Bañón S, Quereda C, Serrano S, Moreno A, Navas E, Rodríguez M, Pérez‐Elías M, Moreno S, Grobler A, Kharsany A, Cawood C, Khanyile D, Puren A, Madurai L, MacLeod W, Fraser N, Bor J, Shubber Z, Carmona S, Pillay Y, Gorgens M, Moyo S, Mohammed T, Kotokwe K, Boleo C, Mupfumi L, Gaseitsiwe S, Musonda R, Bennett K, van Widenfelt E, Gaolathe T, Mmalane M, Holme M, Khan N, Wang R, Wirth K, Tchetgen E, Lockman S, Makhema J, Essex M, Novitsky V, Nakanyala T, Patel S, Sawadogo S, Maher A, Banda K, Wolkon A, Chaturvedi S, Luphala P, Agovi A, Chipadze, Ntema C, Prybylski D, Mabuku I, Lowrance D, Hamunime N, Agolory S, McFarland W, Rodger A, Lampe F, Burman W, Gruhlich A, Friedland G, El‐Sadr W, Neaton J, Emery S, Corbelli G, Molina J, Orkin C, Gatell J, Gerstoft J, Ruxrungtham K, de Souza M, Phillips A, Group F, Masuka N, Goverwa‐Sibanda T, Maphosa T, Tshuma E, Kurauone W, Ngarivume K, Masungo T, Carroll R, Greiger‐Zanlungo P, Blick G, Raw A, Lakhani I, Dlamini D, Munthali A, Chinsinga B, Kadzandira J, Ngwira B, Masiye F, Kaunda‐Khangamwa B, Torriente A, Licata M, Mabhele S, Virga A, Nininahazwe C, Ndayizeye N, Kabanga J, project T, Stangl A, Singh D, Windle M, Sievwright K, Footer K, Iovita A, Mukasa S, Baral S, Davis S, Hart M, de Lima C, De Castro D, de Lima Pereira M, Santana D, Aguiar P, Myers L, Hajiyiannis H, Motuba T, Delate R, Mahlasela L, Biello K, Coffey‐Esquivel J, Hosek S, Belzer M, Sullivan P, Mimiaga M, Oleson S, Taylor S, Kreh L, Mayer K, Souleymanov R, Brennan D, Lachowsky N, Fantus S, Ceranto A, Remien R, Mellins C, Robbins R, Gouse H, Leu C, Rowe J, Henry M, Myer L, Stein D, Joska J, Mathias A, Abreu L, Zampieri T, Spiassi A, Gutierrez E, Tun W, Aung P, Bajracharya A, Yam E, Ryan C, Oo S, Thein Z, Paing A, Pasricha N, Willenberg L, Agius P, Sein T, Htun S, Latt N, Luchters S, Vu L, Pulerwitz J, Zieman B, Okal J, Yam E, Project L, Anderson A, Stern E, Mokganyetji T, Rebombo D, MacPhail C, Khoza N, Treves‐Kagan S, Selin A, Peacock D, Pettifor A, Lippman S, Kahn K, Twine R, Gibbs A, Ntini N, Khumalo T, Washington L, Mbatha N, Chirwa E, Willan S, Sikweyiya Y, Jama‐Shai N, Jewkes R, McClair T, Hossain T, Sultana N, Yam E, Zieman B, Hossain S, Yasmin R, Sadiq N, Carter A, Greene S, Hankins C, Brotto L, Money D, Kestler M, Patterson S, O'Brien N, Salters K, Ding E, Webster K, Nicholson V, Sanchez M, Desbiens M, Dubuc D, Lin S, Hogg R, de Pokomandy A, Loutfy, Kaida A, Team C, Chirowodza A, Williams D, Diergaardt C, Adetokunboh O, Gede S, Gobodo N, Makeleni N, Tuswa N, Eckard M, O'rie T, Shingwenyana N, Green B, Oluwatimilehin I, Jacobs D, Mabuse R, Maartens T, Dikgale F, Sithole J, Thambinayagam A, Ndirangu J, Leonard W, Uwamahoro D, Uwacu T, Ishimwe A, Mutaganzwa A, Chang E, Ngirabega J, Mwakangalu D, Nzaro M, Mwamzandi Y, Mwero B, Makori J, Mlongo R, Bunu A, Kegoli S, Njoroge A, Motoku J, Muriithi C, Mutisya I, Cale E, Gorman J, Radakovich N, Ozorowski G, Crooks E, Osawa K, Asokan M, Doria‐Rose N, Ward A, Kwong P, Binley J, Mascola J, Ranasinghe S, Lamothe‐Molina P, Soghoian D, Kaizer S, Cole M, Shalek A, Yosef N, Jones B, Carrington M, Streeck H, Kaufmann D, Picker L, Kappler J, Walker B, Mduluza T, Dzoro S, Bedi K, Mpoloka W, Dutrieux J, Maarifi G, Portilho D, Arhel N, Chelbi‐Alix M, Nisole S, Chen S, Tang J, Chen Z, Mocroft A, Achra A, Ross M, Ryom L, Avihingsanon A, Bakowska E, Belloso W, Clarke A, Furrer H, Lucas G, Ristola M, Rassool, Ross J, Somboonwit C, Wyatt C, Group O, Maponga T, Vermeulen H, Robertson B, Burmeister S, Preiser W, Kew M, Andersson M, Bucek A, Leu C, Benson S, Warne P, Abrams E, Elkington K, Dolezal C, Wiznia A, Mellins C, Mogambery J, Dawood H, Wilson D, Moodley A, Alejos B, Hernando V, del Amo J, Rubio R, Montero M, Rivero M, Hernández‐Quero J, Muga R, Gutierrez F, Moreno S, Coris, Mosepele M, Mokgatlhe L, Hudson P, Letsatsi V, Gross R, Nyaboke I, Pengo V, Ojuok S, Athiambo M, Okello E, Otieno F, Plank R, Bailey R, Little M, Fox A, Agot K, Grund J, Mboya E, Musingila P, Omanga E, Emusu D, Odoyo‐June E, Ohaga S, Otieno‐Nyunya B, Awori Q, Lee R, Li P, Ouma D, Obura N, Oundo M, Mwamkita D, Chirchir B, Barasa M, Kirui M, Macharia P, Oketch J, Otiende P, Nyangweso N, Maina M, Kiswi N, Goldstein M, Nyanchoka J, Barone M, Kaufman M, Dam K, Hatzold K, Van Lith L, Ncube G, Lija G, Bonnecwe C, Mavhu W, Kahabuka C, Seifert‐Ahanda K, Marcell A, Mahlasela L, Figueroa M, Njeuhmeli E, Tobian A, Group A, Adera F, Young M, Adipo T, Otieno F, Nordstrom S, Mehta S, Bailey R, McClelland R, Lingappa, John‐Stewart G, Kinuthia J, Yuhas K, Jaoko W, Srinivasan S, Mandaliya K, Fiedler T, Munch M, Richardson B, Overbaugh J, Fredricks D, Decker M, Tomko C, Wingo E, Peitzmeier S, Sawyer A, Glass N, Sherman S, van der Straten A, Shapley‐Quinn M, Reddy K, Cheng H, Etima J, Woeber K, Musara P, Palanee‐Phillips T, Baeten J, Montgomery E, Team M, Maughan‐Brown B, Evans M, George G, Rosenberg M, Pettifor A, Twine R, Hughes J, Gomez‐Olive F, Wagner R, Selin A, MacPhail C, Kahn K, Stadler J, Delany‐Moretlwe S, Baron D, Ju S, Gray G, Rees H, Group F, Moshabela M, Bukenya D, Darong G, Wamoyi J, Zuma T, Renju J, Nyamukapa C, Ddaaki W, Bonnington O, Seeley J, Hoosegood V, Wringe A, Audet C, Ngobeni S, Wagner R, Abdallah S, Ibrahim F, Kirimo M, Mongi A, Baya J, Shossi M, Omar A, Nomsenge S, Thomas A, Hoddinott G, Carolus G, Bond V, Team A, Dube F, Dube M, Mpofu A, Magure T, Taramusi I, Pacahuala C, Stratton T, Masching R, King A, Aspin C, Omare J, Kituku A, McLean E, Renju J, Wamoyi J, Bukenya D, Ddaaki W, Church K, Wringe A, Network A, Barron P, Pillay Y, Sebidi J, Fernandes A, Adeyemi O, Erekaha S, Ogum E, Yunusa F, Swomen H, Barde A, Chime C, Ebagua I, Sam‐Agudu N, Dinanga J, Gill M, Loando A, Nyombe C, Bakwalufu J, Mbonze N, Fwamba F, Ilunga V, Machekano R, Phillips T, Brittain K, Abrams E, Zerbe A, Ronan A, Mellins C, Remien R, Woelk G, Kieffer M, Mpofu D, Cathcart R, Group A, Azizuyo B, Mantsios A, Shembilu C, Mbwambo J, Likindikoki S, Beckham S, Mwampashi A, Leddy A, Galai N, Davis W, Kerrigan D, Duck T, Selvey C, Telfer B, Schmidt H, Price K, Keen P, Cecilio M, Holden J, Vannakit R, Jantarapakde J, Pengnonyang S, Jitjang S, Janamnuaysook R, Pankam T, Trachunthong D, Pussadee K, Reankhomfu R, Lingjongrat D, Janyam S, Nakpor T, Leenasirimakul P, Jadwattanakul T, Noriega S, Charoenying S, Sattayapanich T, Arunmanakul A, Phanuphak P, Cassell M, Phanuphak N, Arthos J, Byrareddy S, Cicala C, Ortiz K, Little D, Gumber S, Hong J, Zurla C, Villinger F, Fauci A, Ansari A, Santangelo P, Gosselin A, Salinas T, Planas D, Wacleche V, Zhang Y, Fromentin R, Mehraj V, Chomont N, Routy J, Ancuta P, Policicchio B, Xu C, Ma D, He T, Raehtz K, Sivanandham R, Kleinman A, Krampe N, Haret‐Richter G, Dunsmore T, Apetrei C, Pandrea I, Ribeiro R, Mota T, Khoury G, Jacobson J, Lu H, Wightman F, Van der Sluis R, Anderson J, Cameron P, Lewin, Purcell D, Hope T, Mamede J, Leidner J, Williams P, Mayondi G, Ajibola G, Holding P, Tepper V, Nichols S, Diseko M, Magetse J, Sakoi M, Moabi K, Makhema J, Mdluli C, Chaudhury S, Petlo C, Jibril H, Kammerer B, Lockman S, Boivin M, Sikorskii A, Aizire J, Maliwichi‐Senganimalunje L, Ogwang L, Kawalazira R, Nyakato M, Familiar I, Ruisenor‐Escudero H, Mallewa M, Taha T, Fowler, McHenry M, Apondi E, Ayaya S, Tu W, Bi G, Sang E, Vreeman R, Njuguna N, Ngure K, Bukusi D, Wamalwa D, Mugo N, Majonga E, Rylance J, Odland J, Kranzer K, McHugh G, Metcalfe J, Bandason T, Mujuru H, Kaski J, Ferrand R, Puthanakit T, Kosalaraksa P, Petdachai W, Hansudewechakul R, Borkird T, Lolekha R, Thaisri H, Samleerat T, Boonsuk S, Ongwandee S, Group O, Wake R, Jarvis J, Harrison T, Mashamaite S, Govender N, Ramjathan P, Reddy N, Mlisana K, Manak M, Shutt A, Hack H, Jagodzinski L, Peel S, Danboise B, Tang N, Pahalawatta V, Frank A, Lampinen J, Leckie G, Bilkovski R, Bagley Z, Viana R, Wallis C, Abravaya K, Kulkarni S, Jadhav S, Khopkar P, Sane S, Chimanpure V, Dhilpe V, Londhe R, Ghate M, Yelgate R, Panchal N, Rahane G, Rewari B, Gangakhedkar R, Sutcliffe C, Thuma P, Sinywimaanzi K, Hamahuwa M, Moss W, Davey D, Wall K, Inambao M, Kilembe W, Brill I, Chomba E, Khu N, Mulenga J, Tichacek A, Vwalika B, Allen S, Group R, Heffron R, Mugo N, Ngure K, Bukusi E, Odoyo J, Katabira E, Bulya N, Asiimwe S, Tindimwebwa E, Haberer J, Marzinke M, Celum C, Baeten J, Maman D, Huerga H, Van Cutsem G, Mukui I, Chilima B, Hennequin W, Masiku C, Salumu L, Ellman T, Etard J, Schwartz S, Phofa R, Yende N, Bassett J, Sanne I, Van Rie A, Davies N, Mullick S, Schwartz S, Kaida A, Kabakyenga J, Bwana M, Bajunirwe F, Bennett K, Haberer J, Boum Y, Martin J, Hunt P, Bangsberg, Matthews, Moodley K, Staunton C, Duby Z, Hendricks M, Roussow T, de Roubaix M, Nair G, Skinner D, Salzwedel J, Hannah S, Taylor J, Dube K, Power J, Lucke J, Dowsett G, Brown G, Lyons A, Evans D, Taylor J, Sylla L, Garner S, Weiner B, Skinner A, Greene S, Rennie S, Dubé K, Garner S, Rennie S, Ananworanich J, Dube K, Margolis D, Sugarman J, Tressler R, Gilbertson A, Dawson L, Mathews A, Anderson A, Farley S, Hightow‐Weidman L, Muessig K, Rennie S, Tucker J, Kiriazova T, Sereda Y, Neduzhko O, Postnov O, Yorick R, Shvab I, Dvoriak S, Garone D, Mateyu G, van Oosterhout J, Singano V, van Schoor V, Chigayo M, Ndindi H, Kwekwesa A, Gaven S, Harawa K, Zandamela A, Mobaracaly, Benedetti M, Solomon D, Bernardo V, Topp S, Moonga C, Mudenda C, Chileshe C, Magwende G, Heymann S, Henostroza G, Ingleby C, Ayalew M, Ponde T, Wall K, Inamba M, Kilembe W, Karita E, Vwalika B, Mulenga J, Parker R, Sharkey T, Tichacek A, Hunter E, Yohnka R, Abdallah J, Allen S, Galarraga O, Wamai R, Sosa‐Rubi S, Mugo M, Contreras D, Bautista‐Arredondo S, Nyakundi H, Wang'ombe J, Wilhelm A, Amole C, Middlecote C, Harwell J, McCarthy E, Sosa‐Rubí S, Bautista‐Arredondo S, Opuni M, Contreras‐Loya D, La Hera‐Fuentes G, Salas‐Ortiz A, Kwan A, Condo J, Dzekedzeke K, Galárraga O, Martinson N, Masiye F, Nsanzimana S, Wamai R, Wang'ombe J, Torres‐Rueda S, Weiss H, Wambura M, Mahler H, Chilongani J, Kuringe E, Hayes R, Plotkin M, Makokha M, Hellar A, Schutte C, Mshana G, Larke N, Lija G, Changalucha J, Grund J, Terris‐Prestholt F, Gotham D, Barber M, Fortunak J, Pozniak A, Hill A. Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa Journal Of The International AIDS Society 2016, 19: 21264. PMID: 27460772, PMCID: PMC4960637, DOI: 10.7448/ias.19.6.21264.
  • The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.Walensky RP, Borre ED, Bekker LG, Resch SC, Hyle EP, Wood R, Weinstein MC, Ciaranello AL, Freedberg KA, Paltiel AD. The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa. Annals Of Internal Medicine 2016, 165: 325-33. PMID: 27240120, PMCID: PMC5012932, DOI: 10.7326/m16-0799.
  • Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel StrategiesOuattara EN, Robine M, Eholié SP, MacLean RL, Moh R, Losina E, Gabillard D, Paltiel AD, Danel C, Walensky RP, Anglaret X, Freedberg KA. Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies Clinical Infectious Diseases 2016, 62: 1454-1462. PMID: 26936666, PMCID: PMC4872286, DOI: 10.1093/cid/ciw117.
  • Authors' ReplyLuz PM, Grinsztejn B, Veloso VG, Paltiel AD. Authors' Reply JAIDS Journal Of Acquired Immune Deficiency Syndromes 2016, 71: e56. PMID: 26579987, PMCID: PMC4712134, DOI: 10.1097/qai.0000000000000902.
  • Survival benefits of antiretroviral therapy in Brazil: a model‐based analysisLuz PM, Girouard MP, Grinsztejn B, Freedberg KA, Veloso VG, Losina E, Struchiner CJ, MacLean RL, Parker RA, Paltiel AD, Walensky RP. Survival benefits of antiretroviral therapy in Brazil: a model‐based analysis Journal Of The International AIDS Society 2016, 19: 20623. PMID: 27029828, PMCID: PMC4814587, DOI: 10.7448/ias.19.1.20623.
  • Model-based evaluation of cost-effectiveness of nerve growth factor inhibitors in knee osteoarthritis: impact of drug cost, toxicity, and means of administrationLosina E, Michl G, Collins JE, Hunter DJ, Jordan JM, Yelin E, Paltiel AD, Katz JN. Model-based evaluation of cost-effectiveness of nerve growth factor inhibitors in knee osteoarthritis: impact of drug cost, toxicity, and means of administration Osteoarthritis And Cartilage 2015, 24: 776-785. PMID: 26746146, PMCID: PMC4838505, DOI: 10.1016/j.joca.2015.12.011.
  • Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV InfectionWalensky RP, Jacobsen MM, Bekker LG, Parker RA, Wood R, Resch SC, Horstman NK, Freedberg KA, Paltiel AD. Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection The Journal Of Infectious Diseases 2015, 213: 1523-1531. PMID: 26681778, PMCID: PMC4837902, DOI: 10.1093/infdis/jiv523.
  • The Epi-TAF for Tenofovir Disoproxil Fumarate?Walensky RP, Horn TH, Paltiel AD. The Epi-TAF for Tenofovir Disoproxil Fumarate? Clinical Infectious Diseases 2015, 62: 915-918. PMID: 26658300, DOI: 10.1093/cid/civ1000.
  • The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United StatesGirouard MP, Sax PE, Parker RA, Taiwo B, Freedberg KA, Gulick RM, Weinstein MC, Paltiel AD, Walensky RP. The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States Clinical Infectious Diseases 2015, 62: 784-791. PMID: 26658053, PMCID: PMC4772845, DOI: 10.1093/cid/civ981.
  • Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the USPei PP, Weinstein MC, Li XC, Hughes MD, Paltiel AD, Hou T, Parker RA, Gaynes MR, Sax PE, Freedberg KA, Schackman BR, Walensky RP. Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US HIV Research & Clinical Practice 2015, 16: 207-218. PMID: 26651525, PMCID: PMC4718767, DOI: 10.1080/15284336.2015.1123942.
  • Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbiditiesKatz JN, Smith SR, Collins JE, Solomon DH, Jordan JM, Hunter DJ, Suter LG, Yelin E, Paltiel AD, Losina E. Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities Osteoarthritis And Cartilage 2015, 24: 409-418. PMID: 26525846, PMCID: PMC4761310, DOI: 10.1016/j.joca.2015.10.006.
  • Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US.Pei PP, Weinstein MC, Li XC, Hughes MD, Paltiel AD, Hou T, Parker RA, Gaynes MR, Sax PE, Freedberg KA, Schackman BR, Walensky RP. Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US. HIV Clinical Trials 2015, 1945577115Y0000000009. PMID: 26365741.
  • Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the USPei P, Weinstein M, Li X, Hughes M, Paltiel A, Hou T, Parker R, Gaynes M, Sax P, Freedberg K, Schackman B, Walensky R. Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US HIV Research & Clinical Practice 2015, 1945577115y.000. DOI: 10.1179/1945577115y.0000000009.
  • Defining the Value of Future Research to Identify the Preferred Treatment of Meniscal Tear in the Presence of Knee OsteoarthritisLosina E, Dervan EE, Paltiel AD, Dong Y, Wright RJ, Spindler KP, Mandl LA, Jones MH, Marx RG, Safran-Norton CE, Katz JN. Defining the Value of Future Research to Identify the Preferred Treatment of Meniscal Tear in the Presence of Knee Osteoarthritis PLOS ONE 2015, 10: e0130256. PMID: 26086246, PMCID: PMC4472814, DOI: 10.1371/journal.pone.0130256.
  • Reducing Sexual Violence by Increasing the Supply of Toilets in Khayelitsha, South Africa: A Mathematical ModelGonsalves GS, Kaplan EH, Paltiel AD. Reducing Sexual Violence by Increasing the Supply of Toilets in Khayelitsha, South Africa: A Mathematical Model PLOS ONE 2015, 10: e0122244. PMID: 25923105, PMCID: PMC4414450, DOI: 10.1371/journal.pone.0122244.
  • The Lifetime Medical Cost Savings From Preventing HIV in the United StatesSchackman BR, Fleishman JA, Su AE, Berkowitz BK, Moore RD, Walensky RP, Becker JE, Voss C, Paltiel AD, Weinstein MC, Freedberg KA, Gebo KA, Losina E. The Lifetime Medical Cost Savings From Preventing HIV in the United States Medical Care 2015, 53: 293-301. PMID: 25710311, PMCID: PMC4359630, DOI: 10.1097/mlr.0000000000000308.
  • Could nerve growth factor inhibitors have a place in the treatment of knee osteoarthritis?: Impact of joint destruction and means of administration ossn the value of TanezumabsLosina E, Michl G, Collins J, Hunter D, Jordan J, Yelin E, Paltiel A, Katz J. Could nerve growth factor inhibitors have a place in the treatment of knee osteoarthritis?: Impact of joint destruction and means of administration ossn the value of Tanezumabs Osteoarthritis And Cartilage 2015, 23: a394. DOI: 10.1016/j.joca.2015.02.727.
  • Demographic and clinical features of inclusion body myositis in north AmericaPaltiel AD, Ingvarsson E, Lee DK, Leff RL, Nowak RJ, Petschke KD, Richards‐Shubik S, Zhou A, Shubik M, O'Connor KC. Demographic and clinical features of inclusion body myositis in north America Muscle & Nerve 2015, 52: 527-533. PMID: 25557419, PMCID: PMC4869122, DOI: 10.1002/mus.24562.
  • Lifetime Medical Costs of Knee Osteoarthritis Management in the United States: Impact of Extending Indications for Total Knee ArthroplastyLosina E, Paltiel AD, Weinstein AM, Yelin E, Hunter DJ, Chen SP, Klara K, Suter LG, Solomon DH, Burbine SA, Walensky RP, Katz JN. Lifetime Medical Costs of Knee Osteoarthritis Management in the United States: Impact of Extending Indications for Total Knee Arthroplasty Arthritis Care & Research 2015, 67: 203-215. PMID: 25048053, PMCID: PMC4422214, DOI: 10.1002/acr.22412.
  • Cost-Effectiveness of Genotype Testing for Primary Resistance in BrazilLuz PM, Morris BL, Grinsztejn B, Freedberg KA, Veloso VG, Walensky RP, Losina E, Nakamura YM, Girouard MP, Sax PE, Struchiner CJ, Paltiel AD. Cost-Effectiveness of Genotype Testing for Primary Resistance in Brazil JAIDS Journal Of Acquired Immune Deficiency Syndromes 2015, 68: 152-161. PMID: 25415289, PMCID: PMC4294967, DOI: 10.1097/qai.0000000000000426.
  • The Clinical Role and Cost-Effectiveness of Long-Acting Antiretroviral TherapyRoss EL, Weinstein MC, Schackman BR, Sax PE, Paltiel AD, Walensky RP, Freedberg KA, Losina E. The Clinical Role and Cost-Effectiveness of Long-Acting Antiretroviral Therapy Clinical Infectious Diseases 2015, 60: 1102-1110. PMID: 25583979, PMCID: PMC4366583, DOI: 10.1093/cid/ciu1159.
  • HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?Sax PE, Sypek A, Berkowitz BK, Morris BL, Losina E, Paltiel AD, Kelly KA, Seage GR, Walensky RP, Weinstein MC, Eron J, Freedberg KA. HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy? PLOS ONE 2014, 9: e113031. PMID: 25397616, PMCID: PMC4232561, DOI: 10.1371/journal.pone.0113031.
  • The Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness AnalysisHyle EP, Jani IV, Lehe J, Su AE, Wood R, Quevedo J, Losina E, Bassett IV, Pei PP, Paltiel AD, Resch S, Freedberg KA, Peter T, Walensky RP. The Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness Analysis PLOS Medicine 2014, 11: e1001725. PMID: 25225800, PMCID: PMC4165752, DOI: 10.1371/journal.pmed.1001725.
  • Clinical Impact and Cost-Effectiveness of Making Third-Line Antiretroviral Therapy Available in Sub-Saharan AfricaOuattara EN, Ross EL, Yazdanpanah Y, Wong AY, Robine M, Losina E, Moh R, Walensky RP, Danel C, Paltiel AD, Eholié SP, Freedberg KA, Anglaret X. Clinical Impact and Cost-Effectiveness of Making Third-Line Antiretroviral Therapy Available in Sub-Saharan Africa JAIDS Journal Of Acquired Immune Deficiency Syndromes 2014, 66: 294-302. PMID: 24732870, PMCID: PMC4146647, DOI: 10.1097/qai.0000000000000166.
  • A Marginal Benefit Approach for Vaccinating Influenza “Superspreaders”Skene KJ, Paltiel AD, Shim E, Galvani AP. A Marginal Benefit Approach for Vaccinating Influenza “Superspreaders” Medical Decision Making 2014, 34: 536-549. PMID: 24740238, PMCID: PMC4209160, DOI: 10.1177/0272989x14523502.
  • Misinterpretation of HIV Preexposure Prophylaxis FindingsPaltiel AD, Walensky RP, Freedberg KA. Misinterpretation of HIV Preexposure Prophylaxis Findings Clinical Infectious Diseases 2014, 59: 139-141. PMID: 24729554, PMCID: PMC4305145, DOI: 10.1093/cid/ciu240.
  • Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-EffectivenessBassett IV, Govindasamy D, Erlwanger AS, Hyle EP, Kranzer K, van Schaik N, Noubary F, Paltiel AD, Wood R, Walensky RP, Losina E, Bekker LG, Freedberg KA. Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness PLOS ONE 2014, 9: e85197. PMID: 24465503, PMCID: PMC3898963, DOI: 10.1371/journal.pone.0085197.
  • Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania.Fitzpatrick MC, Hampson K, Cleaveland S, Mzimbiri I, Lankester F, Lembo T, Meyers LA, Paltiel AD, Galvani AP. Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania. Annals Of Internal Medicine 2014, 160: 91-100. PMID: 24592494, PMCID: PMC4084874, DOI: 10.7326/m13-0542.
  • Routine HIV Screening in Portugal: Clinical Impact and Cost-EffectivenessYazdanpanah Y, Perelman J, DiLorenzo MA, Alves J, Barros H, Mateus C, Pereira J, Mansinho K, Robine M, Park JE, Ross EL, Losina E, Walensky RP, Noubary F, Freedberg KA, Paltiel AD. Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness PLOS ONE 2013, 8: e84173. PMID: 24367639, PMCID: PMC3867470, DOI: 10.1371/journal.pone.0084173.
  • The Survival Benefits of Antiretroviral Therapy in South AfricaApril MD, Wood R, Berkowitz BK, Paltiel AD, Anglaret X, Losina E, Freedberg KA, Walensky RP. The Survival Benefits of Antiretroviral Therapy in South Africa The Journal Of Infectious Diseases 2013, 209: 491-499. PMID: 24307741, PMCID: PMC3903379, DOI: 10.1093/infdis/jit584.
  • Cost-Effectiveness of HIV Treatment as Prevention in Serodiscordant CouplesWalensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Paltiel AD, Nakamura YM, Godbole SV, Panchia R, Sanne I, Weinstein MC, Losina E, Mayer KH, Chen YQ, Wang L, McCauley M, Gamble T, Seage GR, Cohen MS, Freedberg KA. Cost-Effectiveness of HIV Treatment as Prevention in Serodiscordant Couples New England Journal Of Medicine 2013, 369: 1715-1725. PMID: 24171517, PMCID: PMC3913536, DOI: 10.1056/nejmsa1214720.
  • Dengue dynamics and vaccine cost-effectiveness in BrazilDurham DP, Mbah M, Medlock J, Luz PM, Meyers LA, Paltiel AD, Galvani AP. Dengue dynamics and vaccine cost-effectiveness in Brazil Vaccine 2013, 31: 3957-3961. PMID: 23791696, PMCID: PMC3755607, DOI: 10.1016/j.vaccine.2013.06.036.
  • Cost-effectiveness of generic antiretroviral therapy--in response.Walensky RP, Paltiel AD, Schackman BR. Cost-effectiveness of generic antiretroviral therapy--in response. Annals Of Internal Medicine 2013, 158: 776-7. PMID: 23689770, DOI: 10.7326/0003-4819-158-10-201305210-00016.
  • Placing a Price on Medical Device Innovation: The Example of Total Knee ArthroplastySuter LG, Paltiel AD, Rome BN, Solomon DH, Thornhill TS, Abrams SK, Katz JN, Losina E. Placing a Price on Medical Device Innovation: The Example of Total Knee Arthroplasty PLOS ONE 2013, 8: e62709. PMID: 23671626, PMCID: PMC3646021, DOI: 10.1371/journal.pone.0062709.
  • Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?Losina E, Daigle ME, Suter LG, Hunter DJ, Solomon DH, Walensky RP, Jordan JM, Burbine SA, Paltiel AD, Katz JN. Disease-modifying drugs for knee osteoarthritis: can they be cost-effective? Osteoarthritis And Cartilage 2013, 21: 655-667. PMID: 23380251, PMCID: PMC3670115, DOI: 10.1016/j.joca.2013.01.016.
  • Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States.Walensky RP, Sax PE, Nakamura YM, Weinstein MC, Pei PP, Freedberg KA, Paltiel AD, Schackman BR. Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States. Annals Of Internal Medicine 2013, 158: 84-92. PMID: 23318310, PMCID: PMC3664029, DOI: 10.7326/0003-4819-158-2-201301150-00002.
  • Home HIV testing: good news but not a game changer.Paltiel AD, Walensky RP. Home HIV testing: good news but not a game changer. Annals Of Internal Medicine 2012, 157: 744-6. PMID: 23044643, PMCID: PMC3661188, DOI: 10.7326/0003-4819-157-10-201211200-00545.
  • Track C Epidemiology and Prevention ScienceRaugi D, Gottlieb G, Sow P, Cherne S, Toure M, Sall F, Traore F, Sy M, Zheng N, N'Doye I, Kiviat N, Hawes S, Group U, Messeri P, Chiasson M, Kall M, Smith R, Brown A, Delpech V, Eritsyan K, Levina O, Smolskaia T, White E, Heimer R, de Vos A, van der Helm J, Prins M, Kretzschmar M, Hontelez J, de Vlas S, Baltussen R, Bakker R, Tanser F, Lurie M, Bärnighausen T, Powers K, Ghani A, Miller W, Hoffman I, Pettifor A, Hosseinipour M, Kamanga G, Martinson F, Cohen M, Dimitrov D, Boily M, Marrazzo J, Brown E, Qian H, Lou J, Ruan Y, Webb G, Shao Y, Vermund S, Morris M, Evans J, Yu M, Briceno A, Page K, Hahn J, Patel S, Schechter M, Muyinda H, Kiwanuka N, Sewankambo N, Spittal P, Fichorova R, Morrison C, Doncel G, Chen P, Kwok C, Chipato T, Salata R, Mauck C, Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, de Bruyn G, Nakku‐Joloba E, Ngure K, Kiarie J, Coombs R, Baeten J, Team P, Polis C, Curtis K, Phillips S, Curtis K, Polis C, Beer L, Oster A, Mattson C, Skarbinski J, Kahle E, Campbell M, Lingappa J, Donnell D, Celum C, Kapiga S, Ondondo R, Mugo N, Mujugira A, Fife K, Mullins J, Baeten J, Study P, Bearnot B, Werner L, Kharsany A, Karim S, Frohlich J, Karim Q, Mapanje C, Rutstein S, Kamanga G, Phiri S, Nsona D, Pettifor A, Rosenberg N, Hoffman I, Miller W, Crane H, Mimiaga M, Feldman B, Fredericksen R, Mugavero M, Willig J, Safren S, Matthews W, Christopoulos K, Boswell S, Kitahata M, Saag M, Mayer K, Systems C, Hesseling A, Passmore J, Gamieldien H, Jones C, Hanekom W, Sodora D, Jaspan H, Hall H, Frazier E, Rhodes P, Holtgrave D, Furlow‐Parmley C, Tang T, Gray K, Cohen S, Skarbinski J, Fishel J, Bradley S, Young P, Mbofana F, Botao C, Zaidi J, Grapsa E, Tanser F, Newell M, Bärnighausen T, Van Renterghem H, Colvin M, de Beer I, Gunthorp J, Odiit M, Thomas L, Jackson H, Getahun M, Grady B, van der Knaap N, van der Loeff M, Heijman T, Speksnijder A, Geskus R, Prins M, Meade C, Watt M, Sikkema K, Deng L, Ranby K, Skinner D, Pieterse D, Kalichman S, Peinado J, Lama J, Gonzales P, Cabello R, Rosas G, Sanchez J, Cao X, Wu Z, Rou K, Pang L, Baral S, Beyrer C, Muessig K, Poteat T, Wirtz A, Decker M, Sherman S, Kerrigan D, Shannon K, Akello M, Muldoon K, Simo A, Muzaaya G, Rosenberg E, Kelley C, O'Hara B, Frew P, Peterson J, Sanchez T, del Rio C, Sullivan P, Oster A, Russell K, Wiegand R, Le B, Valverde E, Forrest D, Cribbin M, Paz‐Bailey G, Group N, Oster A, Johnson C, Le B, Finlayson T, Balaji A, Lansky A, Mermin J, Valleroy L, MacKellar D, Behel S, Paz‐Bailey G, Groups Y, Mayer K, Wang L, Koblin B, Mao C, Mannheimer S, Magnus M, del Rio C, Buchbinder S, Wilton L, Cummings V, Watson C, Griffith S, Wheeler D, Team H, Koblin B, Mayer K, Eshleman S, Wang L, Shoptaw S, del Rio C, Buchbinder S, Magnus M, Mannheimer S, Liu T, Cummings V, Piwowar‐Manning E, Fields S, Griffith S, Elharrar V, Wheeler D, Team H, Mellouk O, Alami K, Rhilani H, Rafif N, Abadie A, Ouarsas L, Bennani A, Omari B, Oumzil I, Johnston L, Rangsin R, Kana K, Chuenchitra T, Sunantarod A, Meesiri S, Areekul W, Nelson K, Khobragade S, Goswami P, Ramakrishnan L, George B, Adhikary R, Ramanathan S, Mathew S, Kumar R, Kodali V, Wirtz A, Trapence G, Jumbe V, Umar E, Ketende S, Kamba D, Berry M, Stromdahl S, Beyrer C, Baral S, Metsch L, Kuo I, Lalota M, Phillips G, Cardenas G, Castel A, Forrest D, West T, Pereyra M, Jia Y, Kolber M, Opoku J, Magnus M, Elkamhawi S, Abaza O, Elghamrawy E, Elmagd S, Ramy H, Atallah S, Elkot N, Kamal M, Mawazini F, Helmy R, Soliman C, Pharris A, Noori T, Likatavicius G, van de Laar M, Baral S, Poteat T, Wirtz A, Stromdahl S, Beyrer C, Okuku H, Wahome E, Duncan S, Thiongo’ A, Mwambi J, Shafi J, Smith A, Graham S, Sanders E, Taylor M, Schillinger J, Pathela P, Skinner J, Newman D, Braunstein S, Shepard C, Brewer T, Ahmed T, Griffin A, Furness B, Cope A, Crooks A, Kuruc J, Sugarbaker A, Hightow‐Weidman L, Eron J, Gay C, Lee S, Roehler M, Guillon G, Schiff E, Delgado‐Borrego A, Friel T, La Marca A, Dickson R, Sulkowski M, Borders J, Allen G, Kurtz L, Kardos K, Gregg R, Muro F, Fiorillo S, Odhiambo C, Cunningham C, Buchanan A, Urbanus A, van de Laar T, Geskus R, Vanhommerig J, van Rooijen M, Schinkel J, Heijman T, Coutinho R, Prins M, Dong Y, Qiu C, Xia X, Wang J, Zhang H, Wang Y, Zhang X, Xu J, Chu P, Santos G, Vu A, Nieves‐Rivera I, Colfax G, Grinsdale J, Huang S, Philip S, Scheer S, Aragon T, Sey K, Ma Y, Song N, Nunes E, Maricato J, Zukurov J, Janini L, Vidanapathirana H, Sangeeth M, Rowan S, Johnson S, Thrun M, Daniloff E, Reirden D, Burman W, Connick E, Gardner E, Mitchell K, Foss A, Prudden H, Pickles M, Williams J, Johnson H, Ramesh B, Washington R, Isac S, Rajaram S, Phillips A, Bradley J, Alary M, Moses S, Lowndes C, Watts C, Boily M, Vickerman P, Wirtz A, Pretorius C, Sherman S, Baral S, Decker M, Sweat M, Beyrer C, Kerrigan D, Suryawanshi D, Swain P, Kumari R, Bhatnagar T, Zhou W, Bharat S, Bhattacharya M, Pandey A, Collumbien M, Marshall B, Paczkowski M, Tempalski B, Pouget E, Friedman S, Galea S, Kessler J, Myers J, Nucifora K, Mensah N, Kowalski A, Sweeney M, Toohey C, Shepard C, Cutler B, Braithwaite S, Tripathi A, Whiteside O, Scanlon C, Duffus W, Marshall B, Paczkowski M, Seemann L, Tempalski B, Pouget E, Galea S, Friedman S, Ahmed T, Griffin A, West T, Pappas G, Metsch L, Pollack H, Abel S, Kunzel C, Greenberg B, Messinger S, Pereyra M, Schouten E, Sinunu M, Wadonda N, Kajawo E, Eliya M, Chimbwandira F, Kellerman S, Lin H, He N, Ding Y, Zhu W, Detels R, Juárez‐Figueroa L, Gonzalez‐Rodríguez A, Casillas J, Rodríguez‐Nolasco E, Iracheta P, Laeyendecker O, Brookmeyer R, Cousins M, Mullis C, Konikoff J, Donnell D, Celum C, Buchbinder S, Seage G, Kirk G, Mehta S, Astemborski J, Jacobson L, Margolick J, Brown J, Quinn T, Eshleman S, Reed J, Justman J, Bicego G, Donnell D, Bock N, Ginindza H, Koler A, Philip N, Makhanya M, Mlambo C, Parekh B, Duong Y, Ellenberger D, Sexton C, Nkambule R, Aghaizu A, Kall M, Smith R, Tosswill J, Murphy G, Delpech V, Kretzschmar M, van der Loeff M, De Angelis D, Coutinho R, Hontelez J, Lurie M, Bärnighausen T, Bakker R, Baltussen R, Tanser F, Hallett T, Newell M, de Vlas S, Walensky R, Ross E, Kumarasamy N, Wood R, Noubary F, Paltiel A, Nakamura Y, Godbole S, Hosseinipour M, Hakim J, Kumwenda J, Makhema J, Akelo V, Panchia R, Sanne I, Weinstein M, Losina E, Mayer K, Grinsztejn B, Pilotto J, Chariyalertsak S, Santos B, Chen Y, Wang L, Li X, McCauley M, Gamble T, Piwowar‐Manning E, Cottle L, Hoffman I, Eron J, Gallant J, Swindells S, Taha T, Nielsen‐Saines K, Celentano D, Essex M, Elharrar V, Burns D, Seage G, Cohen M, Freedberg K, Stover J, Pretorius C, Kato M, Granich R, Vu H, Nadol P, Sabin K, Suthar A, Williams B, Mayer K, Wang L, Hoffman I, McCauley M, Li X, Safren S, Gamble T, Talley J, Cottle L, Piwowar‐Manning E, Akelo V, Badal‐Faesen S, Chotirosniramit N, Fernandes N, Kumarasamy N, Sahay S, Makhema J, Panchia B, Pilotto J, Santos B, Cohen M, McGrath N, Eaton J, Tanser F, Bärnighausen T, Newell M, Bennett D, Jordan M, Bertagnolio S, Hong S, Ravasi G, McMahon J, Kelley K, McMahon J, Elliott J, Hong S, Jordan M, Evans D, Maskew M, Fox M, McNamara L, MacPhail P, Mathews C, Sanne I, Koole O, Tsui S, Wabwire‐Mangen F, Kwesigabo G, Menten J, Mulenga M, Auld A, Agolory S, Mukadi Y, Colebunders R, Bangsberg D, Van Praag E, Torpey K, Williams S, Kaplan J, Zee A, Denison J, Lamb M, Eduardo E, Kandula S, Howard A, Sadr W, Mugisha V, Kimanga D, Kilama B, Elul B, Delpech V, Yin Z, Kall M, Brown A, Benbow N, Scheer S, Wohl A, Brady K, Gagner A, Hughes A, Tejero J, Eberhart M, Hu V, Sayles J, Townsell S, Willis S, Castel A, Griffin A, West T, Shaikh I, Pappas G, Halldorsdottir I, Taruberekera N, Capo‐Chichi V, Firestone R, Vu L, Sherard D, Harrison R, Chan S, Yang B, Wolverton M, Arafat R, Althoff K, Buchacz K, Hall I, Zhang J, Hanna D, Rebeiro P, Gange S, Moore R, Kitahata M, Gebo K, Martin J, Justice A, Horberg M, Hogg R, Sterling T, Cescon A, Klein M, Thorne J, Crane H, Mugavero M, Napravnik S, Kirk G, Jacobson L, Rodriguez B, Brooks J, Research and Design N, Gebre Y, Jack N, Edwards P, Del Riego A, Caffe S, Koul R, Vyas D, Stoové M, Bowring A, Luhmann N, Debaulieu C, Stéphanie D, Pont S, Assouab F, Abdalla T, van Gemert C, Dietze P, Kikumbih N, Nielsen‐Bobbit J, Mbandi A, Motta W, Killian R, Mwanga F, Singh S, Lampe M, Babu A, Rao S, Borkowf C, Nesheim S, Mohammed S, Gupta R, Rao R, Joseph V, Srikantiah P, Kohler P, Okanda J, Kinuthia J, Olilo G, Odhiambo F, Mills L, Kayla L, John‐Stewart G, Kanjipite W, Nikisi J, Chilila M, Shasulwe H, Banda J, Mulilo J, Smit J, Hoffman S, Mabude Z, Beksinska M, Stein Z, Ngoloyi C, Kelvin E, Masvawure T, Pienaar J, Leu C, Exner T, Mantell J, Burgos J, Patterson T, Graff‐Zivin J, Kahn J, Rangel M, Ojeda V, Lozada M, Strathdee S, Adipo T, Westercamp N, Agot K, Jaoko W, Bailey R, Mehta S, Li H, Moses S, Agot K, Maclean I, Hedeker D, Bailey R, Auvert B, Taljaard D, Sitta R, Reach D, Lissouba P, Bouscaillou J, Singh B, Shabangu D, Nhlapo C, Darko J, Mashigo T, Taljaard R, Phatedi G, Tsepe M, Chakela M, Mkhwanazi A, Ntshangase P, Peytavin G, Billy S, Puren A, Lewis D, Sokal D, Awori Q, Barone M, Simba R, Bowa K, Zulz R, Cherutich P, Muraguri N, Wekesa J, Moguche J, Kasonde P, Lee R, Masson P, Perchal P, Combes S, Hart C, Goldstein M, Li P, Vincent M, Kaplan S, Bitega J, Ngeruka M, Karema C, Binagwaho A, Mwandi Z, Ochieng A, Grund J, Mwalili S, Kimanga D, Otieno G, Ohaga S, Oyaro P, Mwangi C, Knight N, Chesang K, Bock N, Reed J, Mirira M, Grund J, Nqeketo A, Ginindza H, Donnell D, Nkambule R, Bicego G, Ryan C, Justman J, Stoové M, El‐Hayek C, Fairley C, Goller J, Leslie D, Roth N, Tee B, Denham I, Chen M, Hellard M, van Aar F, van Weert Y, Spijker R, Götz H, de Coul E, Valverde E, Dinenno E, Oster A, Chavez P, Thomas P, Schulden J, Heffelfinger J, Kahle E, Donnell D, James H, Thomas K, John‐Stewart G, Nakku‐Joloba E, Bukusi E, Lingappa J, Celum C, Baeten J, Study P, Krakower D, Mimiaga M, Rosenberger J, Novak D, Mitty J, White J, Mayer K, Yang D, Chariyalertsak C, Wongthanee A, Kawichai S, Yotruean K, Guadamuz T, Suwanvanichkij V, Beyrer C, Chariyalertsak S, Coleman J, Chaturvedula A, Hendrix C, Team M, van de Vijver D, Nichols B, Abbas U, Cambiano V, Eaton J, Glaubius R, Lythgoe K, Mellors J, Phillips A, Sigaloff K, Hallett T, Mark D, Amico K, Wallace M, Roux S, Grant R, Wood R, Bekker L, Urbina A, Osorio G, Daniel E, Galatowitsch P, Riggan B, Hennessey Z, Sharp V, Underhill K, Morrow K, Operario D, Ducharme R, Kuo C, Mayer K, Smith T, Willis R, Malone A, Moss J, Baum M, Vincent K, Motamedi M, Kennedy S, Gilman J, Butkyavichene I, Nguyen C, Smith T, Malone A, Moss J, Willis R, Baum M, Gilman J, Butkyavichene I, Kennedy S, Nguyen C, Smith T, Massud I, Aung W, Martin A, Bachman S, Mitchell J, Deyounks F, Kersh E, Pau C, Heneine W, Garcia‐Lerma J, Birungi J, Wang H, Ngolobe M, Muldoon K, Khanakwa S, King R, Kaleebu P, Shannon K, Ochai R, Montaner J, Mills E, Laurenco L, Abdallar N, Moore D, Kamwi R, Hamunime N, Odiit M, Gweshe J, Muadinohamba A, Shihepo E, Van Renterghem H, Jonas A, De Klerk M, Mahy M, Forster N, Kahuure K, Anglemyer A, Rutherford G, Baggaley R, Egger M, Siegfried N, Udeagu C, Webster‐León T, Bocour A, Michel P, Shepard C, Holt M, Murphy D, Callander D, Ellard J, Rosengarten M, Kippax S, de Wit J, Gari S, Musheke M, Ntalasha H, Malungo J, Merten S, Ti L, Hayashi K, Kaplan K, Suwannawong P, Montaner J, Wood E, Kerr T, Rimal R, Mkandawire G, Dothi W, Roberts P, Brown J, Limaye R, Cluver L, Orkin M, Boyes M, Kuo C, Gardner F, Kganakga M, Limba J, Dupas P, Sharma V, Makana G, Nekesa C, Duflo E, Tiffany J, Eckenrode J, Exner‐Cortens D, Birnel‐Henderson S, Khan A, Qazi R, Nazim N, Khan A, Wilson D, Zhang L, Kerr C, Kwon A, Hoare A, Williams‐Sherlock M, Avila C, group E, Zule W, Cross H, Go V, Frangakis C, Le M, Viet H, Latkin C, Thi M, Sripaipan T, Davis W, Pham The V, Minh Q, Njenga F, Kiima D, Siminyu M, Munyi E, Abdool R, Muthui M, Lambdin B, Mbwambo J, Mwamburi E, McCurdy S, Pick B, Anderson G, Mital S, Needle R, Carballo‐Diéguez A, Balan I, Frasca T, Dolezal C, Valladares J, Derendinger S, Staub R, Habarta N, Wang G, Mulatu M, Ramakrishnan L, Goswami P, Subramaniam T, Mathew S, Ramanathan S, George B, Adhikary R, Mainkar M, Paranjape R, Brown A, Aghaizu A, Murphy G, Delpech V, Brown A, Gill O, Presanis A, Delpech V, Murphy G, Nicca D, Rasi M, Stoelzl S, Schmid P, Kahlert C, Vernazza P, Study S, Yin L, Wang N, Ruan Y, Shao Y, Vermund S, Qian H, Jones R, Lacroix L, Hoover D, Sivalenka S, Mallachar C, Chava L, Ravi S, Berg R, Ross M, Schmidt A, Weatherburn P, Network E, Robertson L, Mushati P, Eaton J, Dumba L, Mavise G, Makoni J, Schumacher C, Crea T, Monasch R, Sherr L, Garnett G, Nyamukapa C, Gregson S, Tepper V, Kriebs J, Lovelace S, Nair P, Voetsch A, Anderson M, Machakaire E, Bodika S, Jimbo W, Yadav B, Schaan M, Madidimalo T, Lebelonyane R, Webb K, Patel D, Mujaranji G, Engelsmann B, Weber S, Waldura J, Cohan D. Track C Epidemiology and Prevention Science Journal Of The International AIDS Society 2012, 15: 18440-001. PMCID: PMC3501674, DOI: 10.7448/ias.15.5.18440.
  • Conceptualizing a ModelRoberts M, Russell LB, Paltiel AD, Chambers M, McEwan P, Krahn M. Conceptualizing a Model Medical Decision Making 2012, 32: 678-689. PMID: 22990083, DOI: 10.1177/0272989x12454941.
  • Model Parameter Estimation and Uncertainty AnalysisBriggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD. Model Parameter Estimation and Uncertainty Analysis Medical Decision Making 2012, 32: 722-732. PMID: 22990087, DOI: 10.1177/0272989x12458348.
  • The cost-effectiveness of rapid HIV testing in substance abuse treatment: Results of a randomized trialSchackman BR, Metsch LR, Colfax GN, Leff JA, Wong A, Scott CA, Feaster DJ, Gooden L, Matheson T, Haynes LF, Paltiel AD, Walensky RP. The cost-effectiveness of rapid HIV testing in substance abuse treatment: Results of a randomized trial Drug And Alcohol Dependence 2012, 128: 90-97. PMID: 22971593, PMCID: PMC3546145, DOI: 10.1016/j.drugalcdep.2012.08.009.
  • Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2Roberts M, Russell LB, Paltiel AD, Chambers M, McEwan P, Krahn M, Force I. Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2 Value In Health 2012, 15: 804-811. PMID: 22999129, PMCID: PMC4207095, DOI: 10.1016/j.jval.2012.06.016.
  • Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD, Force I. Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 Value In Health 2012, 15: 835-842. PMID: 22999133, DOI: 10.1016/j.jval.2012.04.014.
  • Impact of Program Scale and Indirect Effects on the Cost-Effectiveness of Vaccination ProgramsIbuka Y, Paltiel AD, Galvani AP. Impact of Program Scale and Indirect Effects on the Cost-Effectiveness of Vaccination Programs Medical Decision Making 2012, 32: 442-446. PMID: 22472916, PMCID: PMC3570235, DOI: 10.1177/0272989x12441397.
  • The Cost-effectiveness of Pre-Exposure Prophylaxis for HIV Infection in South African WomenWalensky RP, Park JE, Wood R, Freedberg KA, Scott CA, Bekker LG, Losina E, Mayer KH, Seage GR, Paltiel AD. The Cost-effectiveness of Pre-Exposure Prophylaxis for HIV Infection in South African Women Clinical Infectious Diseases 2012, 54: 1504-1513. PMID: 22474224, PMCID: PMC3334365, DOI: 10.1093/cid/cis225.
  • What Is a Modest Public Health Impact?Yazdanpanah Y, Walensky RP, Rozenbaum W, Yeni P, Paltiel AD. What Is a Modest Public Health Impact? JAMA Internal Medicine 2012, 172: 521-522. PMID: 22450944, DOI: 10.1001/archinternmed.2011.1876.
  • Newer drugs and earlier treatmentSloan CE, Champenois K, Choisy P, Losina E, Walensky RP, Schackman BR, Ajana F, Melliez H, Paltiel AD, Freedberg KA, Yazdanpanah Y. Newer drugs and earlier treatment AIDS 2012, 26: 45-56. PMID: 22008655, PMCID: PMC3237010, DOI: 10.1097/qad.0b013e32834dce6e.
  • Medical Device Innovation — Is “Better” Good Enough?Suter LG, Paltiel AD, Rome BN, Solomon DH, Golovaty I, Gerlovin H, Katz JN, Losina E. Medical Device Innovation — Is “Better” Good Enough? New England Journal Of Medicine 2011, 365: 1464-1466. PMID: 22010911, PMCID: PMC3570242, DOI: 10.1056/nejmp1109285.
  • Resource Utilization and Cost-Effectiveness of Counselor- vs. Provider-Based Rapid Point-of-Care HIV Screening in the Emergency DepartmentWalensky RP, Morris BL, Reichmann WM, Paltiel AD, Arbelaez C, Donnell-Fink L, Katz JN, Losina E. Resource Utilization and Cost-Effectiveness of Counselor- vs. Provider-Based Rapid Point-of-Care HIV Screening in the Emergency Department PLOS ONE 2011, 6: e25575. PMID: 22022415, PMCID: PMC3192047, DOI: 10.1371/journal.pone.0025575.
  • The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: Examining the RV144 trial resultsAndersson KM, Paltiel AD, Owens DK. The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: Examining the RV144 trial results Vaccine 2011, 29: 6107-6112. PMID: 21736912, PMCID: PMC3164284, DOI: 10.1016/j.vaccine.2011.06.076.
  • Dengue vector control strategies in an urban setting: an economic modelling assessmentLuz PM, Vanni T, Medlock J, Paltiel AD, Galvani AP. Dengue vector control strategies in an urban setting: an economic modelling assessment The Lancet 2011, 377: 1673-1680. PMID: 21546076, PMCID: PMC3409589, DOI: 10.1016/s0140-6736(11)60246-8.
  • Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans.Losina E, Walensky RP, Reichmann WM, Holt HL, Gerlovin H, Solomon DH, Jordan JM, Hunter DJ, Suter LG, Weinstein AM, Paltiel AD, Katz JN. Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans. Annals Of Internal Medicine 2011, 154: 217-26. PMID: 21320937, PMCID: PMC3260464, DOI: 10.7326/0003-4819-154-4-201102150-00001.
  • Projected Survival Gains from Revising State Laws Requiring Written Opt-in Consent for HIV TestingApril MD, Chiosi JJ, Paltiel AD, Sax PE, Walensky RP. Projected Survival Gains from Revising State Laws Requiring Written Opt-in Consent for HIV Testing Journal Of General Internal Medicine 2011, 26: 661-667. PMID: 21286837, PMCID: PMC3101973, DOI: 10.1007/s11606-011-1637-5.
  • The Clinical Impact and Cost-Effectiveness of Routine, Voluntary HIV Screening in South AfricaWalensky RP, Wood R, Fofana MO, Martinson NA, Losina E, April MD, Bassett IV, Morris BL, Freedberg KA, Paltiel AD. The Clinical Impact and Cost-Effectiveness of Routine, Voluntary HIV Screening in South Africa JAIDS Journal Of Acquired Immune Deficiency Syndromes 2011, 56: 26-35. PMID: 21068674, PMCID: PMC3005842, DOI: 10.1097/qai.0b013e3181fb8f24.
  • Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based AnalysisWalensky RP, Wood R, Ciaranello AL, Paltiel AD, Lorenzana SB, Anglaret X, Stoler AW, Freedberg KA, . Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based Analysis PLOS Medicine 2010, 7: e1000382. PMID: 21209794, PMCID: PMC3014084, DOI: 10.1371/journal.pmed.1000382.
  • Expanded HIV Screening in the United States: What Will It Cost Government Discretionary and Entitlement Programs? A Budget Impact AnalysisMartin EG, Paltiel AD, Walensky RP, Schackman BR. Expanded HIV Screening in the United States: What Will It Cost Government Discretionary and Entitlement Programs? A Budget Impact Analysis Value In Health 2010, 13: 893-902. PMID: 20950323, PMCID: PMC2999642, DOI: 10.1111/j.1524-4733.2010.00763.x.
  • Routine HIV Screening in France: Clinical Impact and Cost-EffectivenessYazdanpanah Y, Sloan CE, Charlois-Ou C, Le Vu S, Semaille C, Costagliola D, Pillonel J, Poullié AI, Scemama O, Deuffic-Burban S, Losina E, Walensky RP, Freedberg KA, Paltiel AD. Routine HIV Screening in France: Clinical Impact and Cost-Effectiveness PLOS ONE 2010, 5: e13132. PMID: 20976112, PMCID: PMC2956760, DOI: 10.1371/journal.pone.0013132.
  • Scaling Up Circumcision Programs in Southern Africa: The Potential Impact of Gender Disparities and Changes in Condom Use Behaviors on Heterosexual HIV TransmissionAndersson KM, Owens DK, Paltiel AD. Scaling Up Circumcision Programs in Southern Africa: The Potential Impact of Gender Disparities and Changes in Condom Use Behaviors on Heterosexual HIV Transmission AIDS And Behavior 2010, 15: 938-948. PMID: 20924783, PMCID: PMC3112296, DOI: 10.1007/s10461-010-9784-y.
  • Test and Treat DC: Forecasting the Impact of a Comprehensive HIV Strategy in Washington DCWalensky RP, Paltiel AD, Losina E, Morris BL, Scott CA, Rhode ER, Seage GR, Freedberg KA. Test and Treat DC: Forecasting the Impact of a Comprehensive HIV Strategy in Washington DC Clinical Infectious Diseases 2010, 51: 392-400. PMID: 20617921, PMCID: PMC2906630, DOI: 10.1086/655130.
  • Are We Studying What Matters? Health Priorities and NIH-Funded Biomedical Engineering ResearchRubin JB, Paltiel AD, Saltzman WM. Are We Studying What Matters? Health Priorities and NIH-Funded Biomedical Engineering Research Annals Of Biomedical Engineering 2010, 38: 2237-2251. PMID: 20225125, DOI: 10.1007/s10439-010-9982-9.
  • The impact of duration of residence on cause-specific mortality: a cohort study of migrants from the Former Soviet Union residing in Israel and Germany.Ott JJ, Paltiel AM, Winkler V, Becher H. The impact of duration of residence on cause-specific mortality: a cohort study of migrants from the Former Soviet Union residing in Israel and Germany. Health & Place 2010, 16: 79-84. PMID: 19758834, DOI: 10.1016/j.healthplace.2009.08.006.
  • Racial and Sex Disparities in Life Expectancy Losses among HIV-Infected Persons in the United States: Impact of Risk Behavior, Late Initiation, and Early Discontinuation of Antiretroviral TherapyLosina E, Schackman BR, Sadownik SN, Gebo KA, Walensky RP, Chiosi JJ, Weinstein MC, Hicks PL, Aaronson WH, Moore RD, Paltiel AD, Freedberg KA. Racial and Sex Disparities in Life Expectancy Losses among HIV-Infected Persons in the United States: Impact of Risk Behavior, Late Initiation, and Early Discontinuation of Antiretroviral Therapy Clinical Infectious Diseases 2009, 49: 1570-1578. PMID: 19845472, PMCID: PMC2783631, DOI: 10.1086/644772.
  • Medical decision making in patients with knee pain, meniscal tear, and osteoarthritisSuter LG, Fraenkel L, Losina E, Katz JN, Gomoll AH, Paltiel AD. Medical decision making in patients with knee pain, meniscal tear, and osteoarthritis Arthritis & Rheumatism 2009, 61: 1531-1538. PMID: 19877094, PMCID: PMC2804854, DOI: 10.1002/art.24893.
  • Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire AppraisalLosina E, Touré H, Uhler LM, Anglaret X, Paltiel AD, Balestre E, Walensky RP, Messou E, Weinstein MC, Dabis F, Freedberg KA, , . Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal PLOS Medicine 2009, 6: e1000173. PMID: 19859538, PMCID: PMC2762030, DOI: 10.1371/journal.pmed.1000173.
  • 355 DISEASE MODIFYING DRUGS IN KNEE OSTEOARTHRITIS: CAN THEY BE COST-EFFECTIVE?Losina E, Losina E, Niu N, Niu N, Suter L, Hunter D, Hunter D, Holt H, Holt H, Gerlovin H, Gerlovin H, Reichmann W, Reichmann W, Solomon D, Solomon D, Walensky R, Walensky R, Paltiel A, Katz J, Katz J. 355 DISEASE MODIFYING DRUGS IN KNEE OSTEOARTHRITIS: CAN THEY BE COST-EFFECTIVE? Osteoarthritis And Cartilage 2009, 17: s187-s188. DOI: 10.1016/s1063-4584(09)60377-0.
  • When to start antiretroviral therapy in resource-limited settings.Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, Paltiel AD, Anglaret X, Weinstein MC, Losina E. When to start antiretroviral therapy in resource-limited settings. Annals Of Internal Medicine 2009, 151: 157-66. PMID: 19620143, PMCID: PMC3092478, DOI: 10.7326/0003-4819-151-3-200908040-00138.
  • HIV Testing Rates and Outcomes in a South African Community, 2001-2006: Implications for Expanded Screening PoliciesApril MD, Walensky RP, Chang Y, Pitt J, Freedberg KA, Losina E, Paltiel AD, Wood R. HIV Testing Rates and Outcomes in a South African Community, 2001-2006: Implications for Expanded Screening Policies JAIDS Journal Of Acquired Immune Deficiency Syndromes 2009, 51: 310-316. PMID: 19582895, PMCID: PMC3209660, DOI: 10.1097/qai.0b013e3181a248e6.
  • Cost-effectiveness of Total Knee Arthroplasty in the United States: Patient Risk and Hospital VolumeLosina E, Walensky RP, Kessler CL, Emrani PS, Reichmann WM, Wright EA, Holt HL, Solomon DH, Yelin E, Paltiel AD, Katz JN. Cost-effectiveness of Total Knee Arthroplasty in the United States: Patient Risk and Hospital Volume JAMA Internal Medicine 2009, 169: 1113-1121. PMID: 19546411, PMCID: PMC2731300, DOI: 10.1001/archinternmed.2009.136.
  • Price, Performance, and the FDA Approval Process: The Example of Home HIV TestingPaltiel AD, Pollack HA. Price, Performance, and the FDA Approval Process: The Example of Home HIV Testing Medical Decision Making 2009, 30: 217-223. PMID: 19429837, PMCID: PMC2897074, DOI: 10.1177/0272989x09334420.
  • HIV Preexposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost-EffectivenessPaltiel AD, Freedberg KA, Scott CA, Schackman BR, Losina E, Wang B, Seage GR, Sloan CE, Sax PE, Walensky RP. HIV Preexposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost-Effectiveness Clinical Infectious Diseases 2009, 48: 806-815. PMID: 19193111, PMCID: PMC2876329, DOI: 10.1086/597095.
  • Social costs of robbery and the cost‐effectiveness of substance abuse treatmentBasu A, Paltiel AD, Pollack HA. Social costs of robbery and the cost‐effectiveness of substance abuse treatment Health Economics 2008, 17: 927-946. PMID: 17992708, PMCID: PMC3512566, DOI: 10.1002/hec.1305.
  • ReplyWu A, Paltiel A, Kuntz K, Weiss S, Fuhlbrigge A. Reply Journal Of Allergy And Clinical Immunology 2008, 121: 1514-1515. DOI: 10.1016/j.jaci.2008.01.073.
  • Scaling Up Antiretroviral Therapy in South Africa: The Impact of Speed on SurvivalWalensky RP, Wood R, Weinstein MC, Martinson NA, Losina E, Fofana MO, Goldie SJ, Divi N, Yazdanpanah Y, Wang B, Paltiel AD, Freedberg KA. Scaling Up Antiretroviral Therapy in South Africa: The Impact of Speed on Survival The Journal Of Infectious Diseases 2008, 197: 1324-1332. PMID: 18422445, PMCID: PMC2423492, DOI: 10.1086/587184.
  • Modeling the Potential Impact of a Prescription Drug Copayment Increase on the Adult Asthmatic Medicaid PopulationBae SJ, Paltiel AD, Fuhlbrigge AL, Weiss ST, Kuntz KM. Modeling the Potential Impact of a Prescription Drug Copayment Increase on the Adult Asthmatic Medicaid Population Value In Health 2008, 11: 110-118. PMID: 18237365, PMCID: PMC3476042, DOI: 10.1111/j.1524-4733.2007.00219.x.
  • Cost-Effectiveness of HIV Testing and Treatment in the United StatesWalensky RP, Freedberg KA, Weinstein MC, Paltiel AD. Cost-Effectiveness of HIV Testing and Treatment in the United States Clinical Infectious Diseases 2007, 45: s248-s254. PMID: 18190295, PMCID: PMC2365915, DOI: 10.1086/522546.
  • Cost-effectiveness of omalizumab in adults with severe asthma: Results from the Asthma Policy ModelWu AC, Paltiel AD, Kuntz KM, Weiss ST, Fuhlbrigge AL. Cost-effectiveness of omalizumab in adults with severe asthma: Results from the Asthma Policy Model Journal Of Allergy And Clinical Immunology 2007, 120: 1146-1152. PMID: 17904628, PMCID: PMC3476046, DOI: 10.1016/j.jaci.2007.07.055.
  • Predicting the Impact of a Partially Effective HIV Vaccine and Subsequent Risk Behavior Change on the Heterosexual HIV Epidemic in Low- and Middle-Income CountriesAndersson KM, Owens DK, Vardas E, Gray GE, McIntyre JA, Paltiel AD. Predicting the Impact of a Partially Effective HIV Vaccine and Subsequent Risk Behavior Change on the Heterosexual HIV Epidemic in Low- and Middle-Income Countries JAIDS Journal Of Acquired Immune Deficiency Syndromes 2007, 46: 78-90. PMID: 17589368, PMCID: PMC3570247, DOI: 10.1097/qai.0b013e31812506fd.
  • Impact of Expanded HIV ScreeningPaltiel A, Walensky R, Freedberg K. Impact of Expanded HIV Screening Annals Of Internal Medicine 2007, 147: 146. DOI: 10.7326/0003-4819-147-2-200707170-00019.
  • The Effect of Antiretroviral Therapy on Secondary Transmission of HIV among Men Who Have Sex with MenMcCormick AW, Walensky RP, Lipsitch M, Losina E, Hsu H, Weinstein MC, Paltiel AD, Freedberg KA, Seage GR. The Effect of Antiretroviral Therapy on Secondary Transmission of HIV among Men Who Have Sex with Men Clinical Infectious Diseases 2007, 44: 1115-1122. PMID: 17366461, PMCID: PMC2365722, DOI: 10.1086/512816.
  • Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.Paltiel AD, Walensky RP, Schackman BR, Seage GR, Mercincavage LM, Weinstein MC, Freedberg KA. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Annals Of Internal Medicine 2006, 145: 797-806. PMID: 17146064, DOI: 10.7326/0003-4819-145-11-200612050-00004.
  • Cost-Effectiveness of an Intervention to Improve Adherence to Antiretroviral Therapy in HIV-Infected PatientsFreedberg KA, Hirschhorn LR, Schackman BR, Wolf LL, Martin LA, Weinstein MC, Goldin S, Paltiel AD, Katz C, Goldie SJ, Losina E. Cost-Effectiveness of an Intervention to Improve Adherence to Antiretroviral Therapy in HIV-Infected Patients JAIDS Journal Of Acquired Immune Deficiency Syndromes 2006, 43: s113-s118. PMID: 17133193, DOI: 10.1097/01.qai.0000248334.52072.25.
  • The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening.Gross CP, McAvay GJ, Krumholz HM, Paltiel AD, Bhasin D, Tinetti ME. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Annals Of Internal Medicine 2006, 145: 646-53. PMID: 17088577, DOI: 10.7326/0003-4819-145-9-200611070-00006.
  • Rapid HIV testing at home: does it solve a problem or create one?Walensky RP, Paltiel AD. Rapid HIV testing at home: does it solve a problem or create one? Annals Of Internal Medicine 2006, 145: 459-62. PMID: 16983134, DOI: 10.7326/0003-4819-145-6-200609190-00010.
  • Forced Expiratory Volume in 1 Second Percentage Improves the Classification of Severity Among Children With AsthmaFuhlbrigge AL, Weiss ST, Kuntz KM, Paltiel AD. Forced Expiratory Volume in 1 Second Percentage Improves the Classification of Severity Among Children With Asthma Pediatrics 2006, 118: e347-e355. PMID: 16864642, DOI: 10.1542/peds.2005-2962.
  • Fact, Fiction, And Fairness: Resource Allocation Under The Ryan White CARE ActMartin EG, Pollack HA, Paltiel AD. Fact, Fiction, And Fairness: Resource Allocation Under The Ryan White CARE Act Health Affairs 2006, 25: 1103-1112. PMID: 16835192, DOI: 10.1377/hlthaff.25.4.1103.
  • The Survival Benefits of AIDS Treatment in the United StatesWalensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, Weinstein MC, Freedberg KA. The Survival Benefits of AIDS Treatment in the United States The Journal Of Infectious Diseases 2006, 194: 11-19. PMID: 16741877, DOI: 10.1086/505147.
  • Cost-effectiveness of inhaled steroids in asthma: Impact of effect on bone mineral densityFuhlbrigge AL, Bae SJ, Weiss ST, Kuntz KM, Paltiel AD. Cost-effectiveness of inhaled steroids in asthma: Impact of effect on bone mineral density Journal Of Allergy And Clinical Immunology 2006, 117: 359-366. PMID: 16461137, DOI: 10.1016/j.jaci.2005.10.036.
  • Surveillance for isocyanate asthma: a model based cost effectiveness analysisWild DM, Redlich CA, Paltiel AD. Surveillance for isocyanate asthma: a model based cost effectiveness analysis Occupational And Environmental Medicine 2005, 62: 743. PMID: 16234399, PMCID: PMC1740898, DOI: 10.1136/oem.2004.016147.
  • Cost Advantage of Dual-Chamber Versus Single-Chamber Cardioverter-Defibrillator ImplantationGoldberger Z, Elbel B, McPherson CA, Paltiel AD, Lampert R. Cost Advantage of Dual-Chamber Versus Single-Chamber Cardioverter-Defibrillator Implantation Journal Of The American College Of Cardiology 2005, 46: 850-857. PMID: 16139136, DOI: 10.1016/j.jacc.2005.05.061.
  • Optimal Allocation of Testing Dollars: The Example of HIV Counseling, Testing, and ReferralWalensky RP, Weinstein MC, Smith HE, Freedberg KA, Paltiel AD. Optimal Allocation of Testing Dollars: The Example of HIV Counseling, Testing, and Referral Medical Decision Making 2005, 25: 321-329. PMID: 15951459, DOI: 10.1177/0272989x05276955.
  • Cost-Effectiveness of Enfuvirtide in Treatment-Experienced Patients With Advanced HIV DiseaseSax PE, Losina E, Weinstein MC, Paltiel AD, Goldie SJ, Muccio TM, Kimmel AD, Zhang H, Freedberg KA, Walensky RP. Cost-Effectiveness of Enfuvirtide in Treatment-Experienced Patients With Advanced HIV Disease JAIDS Journal Of Acquired Immune Deficiency Syndromes 2005, 39: 69-77. PMID: 15851916, DOI: 10.1097/01.qai.0000160406.08924.a2.
  • Routine human immunodeficiency virus testing: An economic evaluation of current guidelinesWalensky RP, Weinstein MC, Kimmel AD, Seage GR, Losina E, Sax PE, Zhang H, Smith HE, Freedberg KA, Paltiel AD. Routine human immunodeficiency virus testing: An economic evaluation of current guidelines The American Journal Of Medicine 2005, 118: 292-300. PMID: 15745728, DOI: 10.1016/j.amjmed.2004.07.055.
  • Expanded Screening for HIV in the United States — An Analysis of Cost-EffectivenessPaltiel AD, Weinstein MC, Kimmel AD, Seage GR, Losina E, Zhang H, Freedberg KA, Walensky RP. Expanded Screening for HIV in the United States — An Analysis of Cost-Effectiveness New England Journal Of Medicine 2005, 352: 586-595. PMID: 15703423, DOI: 10.1056/nejmsa042088.
  • Cost-Effectiveness of HIV Screening for Incarcerated Pregnant WomenResch S, Altice FL, Paltiel AD. Cost-Effectiveness of HIV Screening for Incarcerated Pregnant Women JAIDS Journal Of Acquired Immune Deficiency Syndromes 2005, 38: 163-173. PMID: 15671801, DOI: 10.1097/01.qai.0000146598.40301.e6.
  • Optimal Frequency of Cd4 Cell Count and HIV Rna Monitoring Prior to Initiation of Antiretroviral Therapy in HIV-Infected PatientsKimmel AD, Goldie SJ, Walensky RP, Losina E, Weinstein MC, Paltiel AD, Zhang H, Freedberg KA. Optimal Frequency of Cd4 Cell Count and HIV Rna Monitoring Prior to Initiation of Antiretroviral Therapy in HIV-Infected Patients Antiviral Therapy 2005, 10: 41-52. PMID: 15751762, DOI: 10.1177/135965350501000102.
  • An Asthma Policy ModelPaltiel A, Kuntz K, Weiss S, Fuhlbrigge A. An Asthma Policy Model 2005, 70: 659-693. DOI: 10.1007/1-4020-8066-2_26.
  • A Single Measure of FEV1 Is Associated With Risk of Asthma Attacks in Long-term Follow-upKitch BT, Paltiel AD, Kuntz KM, Dockery DW, Schouten JP, Weiss ST, Fuhlbrigge AL. A Single Measure of FEV1 Is Associated With Risk of Asthma Attacks in Long-term Follow-up CHEST Journal 2004, 126: 1875-1882. PMID: 15596687, DOI: 10.1378/chest.126.6.1875.
  • A therapeutic HIV vaccine: how good is good enough?Walensky RP, Paltiel AD, Goldie SJ, Gandhi RT, Weinstein MC, Seage GR, Smith HE, Zhang H, Freedberg KA. A therapeutic HIV vaccine: how good is good enough? Vaccine 2004, 22: 4044-4053. PMID: 15364455, DOI: 10.1016/j.vaccine.2004.03.059.
  • Quality of life after aortic valve replacement with tissue and mechanical implantsSedrakyan A, Hebert P, Vaccarino V, Paltiel AD, Elefteriades JA, Mattera J, Lin Z, Roumanis SA, Krumholz HM. Quality of life after aortic valve replacement with tissue and mechanical implants Journal Of Thoracic And Cardiovascular Surgery 2004, 128: 266-272. PMID: 15282464, DOI: 10.1016/j.jtcvs.2003.12.014.
  • Association between preference-based health-related quality of life and asthma severityMoy ML, Fuhlbrigge AL, Blumenschein K, Chapman RH, Zillich AJ, Kuntz KM, Paltiel AD, Kitch BT, Weiss ST, Neumann PJ. Association between preference-based health-related quality of life and asthma severity Annals Of Allergy Asthma & Immunology 2004, 92: 329-334. PMID: 15049396, DOI: 10.1016/s1081-1206(10)61570-0.
  • Age does not limit quality of life improvement in cardiac valve surgerySedrakyan A, Vaccarino V, Paltiel A. Age does not limit quality of life improvement in cardiac valve surgery ACC Current Journal Review 2004, 13: 60. DOI: 10.1016/j.accreview.2003.10.005.
  • Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infectionGoldie SJ, Paltiel AD, Weinstein MC, Losina E, Seage GR, Kimmel AD, Walensky RP, Sax PE, Freedberg KA. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection The American Journal Of Medicine 2003, 115: 632-641. PMID: 14656616, DOI: 10.1016/j.amjmed.2003.07.007.
  • Age does not limit quality of life improvement in cardiac valve surgerySedrakyan A, Vaccarino V, Paltiel AD, Elefteriades JA, Mattera JA, Roumanis SA, Lin Z, Krumholz HM. Age does not limit quality of life improvement in cardiac valve surgery Journal Of The American College Of Cardiology 2003, 42: 1208-1214. PMID: 14522482, DOI: 10.1016/s0735-1097(03)00949-5.
  • PRPI 9: BONE MINERAL DENSITY LOSS AFFECTS ESTIMATES OF THE COSTEFFECTIVENESS OF INHALED STEROIDS IN ASTHMAPaltiel A, Fuhlbrigge A, Kitch B, Rashti R, Weiss S, Lee S, Kuntz K. PRPI 9: BONE MINERAL DENSITY LOSS AFFECTS ESTIMATES OF THE COSTEFFECTIVENESS OF INHALED STEROIDS IN ASTHMA Value In Health 2003, 6: 369. DOI: 10.1016/s1098-3015(10)64272-6.
  • Economic Costs of Influenza-Related Work AbsenteeismAkazawa M, Sindelar JL, Paltiel AD. Economic Costs of Influenza-Related Work Absenteeism Value In Health 2003, 6: 107-115. PMID: 12641861, DOI: 10.1046/j.1524-4733.2003.00209.x.
  • Prevention of Human Immunodeficiency Virus—Related Opportunistic Infections in France: A Cost-Effectiveness AnalysisYazdanpanah Y, Goldie S, Paltiel A, Losina E, Coudeville L, Weinstein M, Gerard Y, Kimmel A, Zhang H, Salamon R, Mouton Y, Freedberg K. Prevention of Human Immunodeficiency Virus—Related Opportunistic Infections in France: A Cost-Effectiveness Analysis Clinical Infectious Diseases 2002, 36: 86-96. PMID: 12491207, DOI: 10.1086/344902.
  • The Cost-Effectiveness of Treatment for Varicocele Related InfertilityPENSON DF, PALTIEL AD, KRUMHOLZ HM, PALTER S. The Cost-Effectiveness of Treatment for Varicocele Related Infertility Investigative Urology 2002, 168: 2490-2494. PMID: 12441947, DOI: 10.1016/s0022-5347(05)64175-4.
  • The Cost-Effectiveness of Treatment for Varicocele Related InfertilityPENSON D, PALTIEL A, KRUMHOLZ H, PALTER S. The Cost-Effectiveness of Treatment for Varicocele Related Infertility Investigative Urology 2002, 168: 2490-2494. DOI: 10.1097/00005392-200212000-00033.
  • Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy.Walensky RP, Goldie SJ, Sax PE, Weinstein MC, Paltiel AD, Kimmel AD, Seage GR, Losina E, Zhang H, Islam R, Freedberg KA. Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy. Journal Of Acquired Immune Deficiency Syndromes (1999) 2002, 31: 27-37. PMID: 12352147, DOI: 10.1097/00126334-200209010-00004.
  • AIDS Drug Assistance Programs: Highlighting Inequities in Human Immunodeficiency Virus–Infection Health Care in the United StatesWalensky RP, Paltiel AD, Freedberg KA. AIDS Drug Assistance Programs: Highlighting Inequities in Human Immunodeficiency Virus–Infection Health Care in the United States Clinical Infectious Diseases 2002, 35: 606-610. PMID: 12173137, DOI: 10.1086/341903.
  • Task Force #2—the cost of prevention: can we afford it? Can we afford not to do it?Krumholz HM, Weintraub WS, Bradford WD, Heidenreich PA, Mark DB, Paltiel AD. Task Force #2—the cost of prevention: can we afford it? Can we afford not to do it? Journal Of The American College Of Cardiology 2002, 40: 603-615. PMID: 12204490, DOI: 10.1016/s0735-1097(02)02083-1.
  • The relationship of preventable opportunistic infections, HIV-1 RNA, and CD4 Cell counts to chronic mortality.Seage GR, Losina E, Goldie SJ, Paltiel AD, Kimmel AD, Freedberg KA. The relationship of preventable opportunistic infections, HIV-1 RNA, and CD4 Cell counts to chronic mortality. Journal Of Acquired Immune Deficiency Syndromes (1999) 2002, 30: 421-8. PMID: 12138349, DOI: 10.1097/00042560-200208010-00008.
  • State AIDS Drug Assistance ProgramsJohri M, Paltiel A, Goldie S, Freedberg K. State AIDS Drug Assistance Programs Medical Care 2002, 40: 429-441. PMID: 11961477, DOI: 10.1097/00005650-200205000-00008.
  • Prophylaxis for Human Immunodeficiency Virus–Related Pneumocystis carinii Pneumonia: Using Simulation Modeling to Inform Clinical GuidelinesGoldie SJ, Kaplan JE, Losina E, Weinstein MC, Paltiel AD, Seage GR, Craven DE, Kimmel AD, Zhang H, Cohen CJ, Freedberg KA. Prophylaxis for Human Immunodeficiency Virus–Related Pneumocystis carinii Pneumonia: Using Simulation Modeling to Inform Clinical Guidelines JAMA Internal Medicine 2002, 162: 921-928. PMID: 11966344, DOI: 10.1001/archinte.162.8.921.
  • Impact of Site of Care, Race, and Hispanic Ethnicity on Medication Use for Childhood AsthmaOrtega AN, Gergen PJ, Paltiel AD, Bauchner H, Belanger KD, Leaderer BP. Impact of Site of Care, Race, and Hispanic Ethnicity on Medication Use for Childhood Asthma Pediatrics 2002, 109: e1-e1. PMID: 11773569, DOI: 10.1542/peds.109.1.e1.
  • A novel approach to defining the relationship between lung function and symptom status in asthmaKuntz KM, Kitch BT, Fuhlbrigge AL, Paltiel AD, Weiss ST. A novel approach to defining the relationship between lung function and symptom status in asthma Journal Of Clinical Epidemiology 2002, 55: 11-18. PMID: 11781117, DOI: 10.1016/s0895-4356(01)00412-7.
  • Use of Health Services by Insurance Status Among Children With AsthmaOrtega A, Belanger K, Paltiel A, Horwitz S, Bracken M, Leaderer B. Use of Health Services by Insurance Status Among Children With Asthma Medical Care 2001, 39: 1065-1074. PMID: 11567169, DOI: 10.1097/00005650-200110000-00004.
  • RS4: A MODEL-BASED EVALUATION OF INHALED STEROIDS IN MILD-TO-MODERATE ASTHMAPaltiel A, Fuhlbrigge A, Kitch B, Weiss S, Neumann P, Kuntz K. RS4: A MODEL-BASED EVALUATION OF INHALED STEROIDS IN MILD-TO-MODERATE ASTHMA Value In Health 2001, 4: 65-66. DOI: 10.1046/j.1524-4733.2001.40201-48.x.
  • Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohortsYazdanpanah Y, Chêne G, Losina E, Goldie S, Merchadou L, Alfandari S, Seage G, Sullivan L, Marimoutou C, Paltiel A, Salamon R, Mouton Y, Freedberg K. Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts International Journal Of Epidemiology 2001, 30: 864-871. PMID: 11511618, DOI: 10.1093/ije/30.4.864.
  • Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: Results from the Asthma Policy ModelPaltiel AD, Fuhlbrigge AL, Kitch BT, Liljas B, Weiss ST, Neumann PJ, Kuntz KM. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: Results from the Asthma Policy Model Journal Of Allergy And Clinical Immunology 2001, 108: 39-in4. PMID: 11447380, DOI: 10.1067/mai.2001.116289.
  • Lifetime Cost of HIV Care in France during the Era of Highly Active Antiretroviral TherapyYazdanpanah Y, Goldie SJ, Losina E, Weinstein MC, Lebrun T, Paltiel AD, Seage GR, Leblanc G, Ajana F, Kimmel AD, Zhang H, Salamon R, Mouton Y, Freedberg KA. Lifetime Cost of HIV Care in France during the Era of Highly Active Antiretroviral Therapy Antiviral Therapy 2001, 7: 257-266. PMID: 12553480, DOI: 10.1177/135965350200700405.
  • The Cost Effectiveness of Combination Antiretroviral Therapy for HIV DiseaseFreedberg K, Losina E, Weinstein M, Paltiel A, Cohen C, Seage G, Craven D, Zhang H, Kimmel A, Goldie S. The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease New England Journal Of Medicine 2001, 344: 824-831. PMID: 11248160, DOI: 10.1056/nejm200103153441108.
  • Preevaluation of Clinical Trial Data: The Case of Preemptive Cytomegalovirus Therapy in Patients with Human Immunodeficiency VirusPaltiel A, Goldie S, Losina E, Weinstein M, Seage G, Kimmel A, Zhang H, Freedberg K. Preevaluation of Clinical Trial Data: The Case of Preemptive Cytomegalovirus Therapy in Patients with Human Immunodeficiency Virus Clinical Infectious Diseases 2001, 32: 783-793. PMID: 11229847, DOI: 10.1086/319223.
  • FEV1 is associated with risk of asthma attacks in a pediatric populationFuhlbrigge A, Kitch B, Paltiel A, Kuntz K, Neumann P, Dockery D, Weiss S. FEV1 is associated with risk of asthma attacks in a pediatric population Journal Of Allergy And Clinical Immunology 2001, 107: 61-67. PMID: 11149992, DOI: 10.1067/mai.2001.111590.
  • Model-Based Drug Evaluation in Chronic Disease: Promise, Pitfalls, and Positioning*Paltiel A. Model-Based Drug Evaluation in Chronic Disease: Promise, Pitfalls, and Positioning* Therapeutic Innovation & Regulatory Science 2001, 35: 131-139. DOI: 10.1177/009286150103500114.
  • Remarks on the role of economic modeling.Paltiel AD. Remarks on the role of economic modeling. Sexually Transmitted Diseases 2000, 27: 610-6. PMID: 11099076, DOI: 10.1097/00007435-200011000-00009.
  • A Model of HIV Patient Care: Methods and Applications to the Cost-Effectiveness of Anti-Viral TherapyPaltiel A, Goldie S, Seage G, Losina E, Weinstein M, Cohen C, Craven D, Freedberg K. A Model of HIV Patient Care: Methods and Applications to the Cost-Effectiveness of Anti-Viral Therapy Sexually Transmitted Diseases 2000, 27: 650-651. DOI: 10.1097/00007435-200011000-00026.
  • Five Minutes with the GovernorPaltiel AD. Five Minutes with the Governor Medical Decision Making 2000, 20: 239-242. PMID: 10772361, DOI: 10.1177/0272989x0002000209.
  • Evaluation of Therapeutic Strategies: A New Method for Balancing Risk and BenefitTroche C, Paltiel A, Makuch R. Evaluation of Therapeutic Strategies: A New Method for Balancing Risk and Benefit Value In Health 2000, 3: 12-22. PMID: 16464177, DOI: 10.1046/j.1524-4733.2000.31002.x.
  • The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS.Scharfstein JA, Paltiel AD, Weinstein MC, Seage GR, Losina E, Craven DE, Freedberg KA. The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS. International Journal Of Technology Assessment In Health Care 1999, 15: 531-47. PMID: 10874380, DOI: 10.1017/s026646239901538x.
  • Postexposure prophylaxis following HIV exposure.Kahn JG, Pinkerton SD, Paltiel AD. Postexposure prophylaxis following HIV exposure. JAMA 1999, 281: 1269-70. PMID: 10208135.
  • Acute Scrotal Symptoms in Boys With an Indeterminate Clinical Presentation: Comparison of Color Doppler Sonography and ScintigraphyPaltiel H, Connolly L, Atala A, Paltiel A, Zurakowski D, Treves S. Acute Scrotal Symptoms in Boys With an Indeterminate Clinical Presentation: Comparison of Color Doppler Sonography and Scintigraphy Investigative Urology 1999, 161: 1408. DOI: 10.1016/s0022-5347(01)61728-2.
  • Acute Scrotal Symptoms in Boys With an Indeterminate Clinical PresentationPaltiel H, Connolly L, Atala A, Paltiel A, Zurakowski D, Treves S. Acute Scrotal Symptoms in Boys With an Indeterminate Clinical Presentation Investigative Urology 1999, 161: 1408.. DOI: 10.1097/00005392-199904000-00140.
  • Acute Scrotal Symptoms in Boys With an Indeterminate Clinical Presentation: Comparison of Color Doppler Sonography and ScintigraphyPaltiel J, Connolly L, Atala A, Paltiel A, Zurakowski D, Treves S. Acute Scrotal Symptoms in Boys With an Indeterminate Clinical Presentation: Comparison of Color Doppler Sonography and Scintigraphy Investigative Urology 1998, 160: 1597-1598. DOI: 10.1016/s0022-5347(01)62655-7.
  • Acute Scrotal Symptoms in Boys With an Indeterminate Clinical PresentationPaltiel J, Connolly L, Atala A, Paltiel A, Zurakowski D, Treves S. Acute Scrotal Symptoms in Boys With an Indeterminate Clinical Presentation Investigative Urology 1998, 160: 1597-1598.. DOI: 10.1097/00005392-199810000-00157.
  • Cost Effectiveness of Prophylaxis for Opportunistic Infections in AIDSFreedberg K, Paltiel A. Cost Effectiveness of Prophylaxis for Opportunistic Infections in AIDS PharmacoEconomics 1998, 14: 165-173. PMID: 10186457, DOI: 10.2165/00019053-199814020-00005.
  • The Cost-Effectiveness of Preventing Cytomegalovirus Disease in AIDS PatientsPaltiel A, Freedberg K. The Cost-Effectiveness of Preventing Cytomegalovirus Disease in AIDS Patients Interfaces 1998, 28: 34-51. DOI: 10.1287/inte.28.3.34.
  • A Monte Carlo Simulation of Advanced HIV DiseasePaltiel AD, Scharfstein JA, Seage GR, Losina E, Goldie SJ, Weinstein MC, Craven DE, Freedberg KA. A Monte Carlo Simulation of Advanced HIV Disease Medical Decision Making 1998, 18: s93-s105. PMID: 9566470, DOI: 10.1177/0272989x98018002s11.
  • Acute scrotal symptoms in boys with an indeterminate clinical presentation: comparison of color Doppler sonography and scintigraphy.Paltiel HJ, Connolly LP, Atala A, Paltiel AD, Zurakowski D, Treves ST. Acute scrotal symptoms in boys with an indeterminate clinical presentation: comparison of color Doppler sonography and scintigraphy. Radiology 1998, 207: 223-31. PMID: 9530319, DOI: 10.1148/radiology.207.1.9530319.
  • The Cost-effectiveness of Preventing AIDS-Related Opportunistic InfectionsFreedberg KA, Scharfstein JA, Seage GR, Losina E, Weinstein MC, Craven DE, Paltiel AD. The Cost-effectiveness of Preventing AIDS-Related Opportunistic Infections JAMA 1998, 279: 130-136. PMID: 9440663, DOI: 10.1001/jama.279.2.130.
  • Resource Allocation and the Funding of HIV PreventionPaltiel A, Stinnett A. Resource Allocation and the Funding of HIV Prevention 1998, 135-152. DOI: 10.1007/978-1-4899-1878-9_10.
  • The Cost-Effectiveness of HIV TestingPaltiel AD, Kaplan EH. The Cost-Effectiveness of HIV Testing Medical Decision Making 1997, 17: 490-495. PMID: 9343808, DOI: 10.1177/0272989x9701700415.
  • The Cost-Effectiveness of Fluconazole Prophylaxis against Primary Systemic Fungal Infections in AIDS PatientsScharfstein JA, Paltiel AD, Freedberg KA. The Cost-Effectiveness of Fluconazole Prophylaxis against Primary Systemic Fungal Infections in AIDS Patients Medical Decision Making 1997, 17: 373-381. PMID: 9343795, DOI: 10.1177/0272989x9701700402.
  • Estimating CE Ratios under Second-order UncertaintyStinnett AA, Paltiel AD. Estimating CE Ratios under Second-order Uncertainty Medical Decision Making 1997, 17: 483-489. PMID: 9343807, DOI: 10.1177/0272989x9701700414.
  • Why Training is the Key to Successful Guideline ImplementationPaltiel A, Neumann P. Why Training is the Key to Successful Guideline Implementation PharmacoEconomics 1997, 12: 297-302. PMID: 10170454, DOI: 10.2165/00019053-199712030-00001.
  • Organ Allocation and the Secretary ProblemPaltiel A. Organ Allocation and the Secretary Problem Medical Decision Making 1997, 17: 231-232. PMID: 9107620, DOI: 10.1177/0272989x9701700215.
  • Mathematical programming for the efficient allocation of health care resourcesStinnett A, Paltiel A. Mathematical programming for the efficient allocation of health care resources Journal Of Health Economics 1996, 15: 641-653. PMID: 10164046, DOI: 10.1016/s0167-6296(96)00493-6.
  • Cost-effectiveness of cancer screening in end-stage renal disease.Chertow GM, Paltiel AD, Owen WF, Lazarus JM. Cost-effectiveness of cancer screening in end-stage renal disease. Archives Of Internal Medicine 1996, 156: 1345-50. PMID: 8651845.
  • Making Health Policy Decisions: Is Human Instinct Rational? Is Rational Choice Human?Paltiel A, Stinnett A. Making Health Policy Decisions: Is Human Instinct Rational? Is Rational Choice Human? Chance 1996, 9: 34-39. DOI: 10.1080/09332480.1996.10555000.
  • Economic Evaluation of HIV Testing Among Intravenous Drug Users: An Analytic Framework and Its Application to ItalyVillari P, Fattore G, Siegel J, Paltiel A, Weinstein M. Economic Evaluation of HIV Testing Among Intravenous Drug Users: An Analytic Framework and Its Application to Italy International Journal Of Technology Assessment In Health Care 1996, 12: 336-357. PMID: 8707505, DOI: 10.1017/s0266462300009673.
  • The FDA And Regulation Of Cost-Effectiveness ClaimsNeumann P, Ƶinner D, Paltiel A. The FDA And Regulation Of Cost-Effectiveness Claims Health Affairs 1996, 15: 54-71. PMID: 8854508, DOI: 10.1377/hlthaff.15.3.54.
  • The epidemiological and economic consequences of AIDS clinical trials.Paltiel AD, Kaplan EH. The epidemiological and economic consequences of AIDS clinical trials. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1993, 6: 179-90. PMID: 8433283.
  • Book reviewPaltiel A. Book review Policy Sciences 1992, 25: 77-79. DOI: 10.1007/bf00144634.
  • Modeling zidovudine therapy: a cost-effectiveness analysis.Paltiel AD, Kaplan EH. Modeling zidovudine therapy: a cost-effectiveness analysis. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1991, 4: 795-804. PMID: 1906934.
  • Nonrandom Mixing Models of HIV TransmissionKaplan E, Cramton P, Paltiel A. Nonrandom Mixing Models of HIV Transmission 1989, 83: 218-239. DOI: 10.1007/978-3-642-93454-4_10.
Edit Profile